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Abstract
The primary objective of this study was to compare the anti-inflammatory effects of
phenolic and volatile compounds extracted from cranberries. The Griess Reagent System assay
was used to measure the in vitro anti-inflammatory capabilities of cranberry phenolic and
volatile extracts on RAW 264.7 mouse macrophage cells. This study tested the antiinflammatory capabilities of the cranberry phenolic and volatile extracts before, as a preventative
treatment, and after, as a means of treating pre-existing inflammation, inducing inflammation
with lipopolysaccharide (LPS). All experiments were conducted in the following manner,
varying only in whether treated with the extracts before or after LPS: 1 x 103 RAW 264.7 cells
were seeded into individual wells of a 96 well plate, given 16 hr to attach, and treated with the
phenolic and volatile extracts at 2x, 4x, and 8x dilutions of their respective starting
concentrations present in a cranberry for 1 hr either before or after 24 hr of induced inflammation
by LPS. Then, nitric oxide (NO) levels were measured to assess the anti-inflammatory
capabilities. When treated with the extracts after LPS, the phenolic 635.7 ppm, 317.8 ppm and
volatile 1.8 ppm NO levels were significantly lower than the positive control, reduced by 62%,
46%, and 50% respectively. When treated before LPS, the phenolic 635.7 ppm, 317.8 ppm and
volatile 1.8 ppm, 0.9 ppm NO levels were significantly lower than the positive control, reduced
by 52%, 25%, 47%, and 13% respectively. Upon overall evaluation, the phenolic and volatile
extracts’ anti-inflammatory capabilities were very comparable even though the volatiles were at
a 353x lower concentration, and an overall stronger preventative effect was observed. Future
studies are needed to reveal the mechanisms by which these compounds act to prevent and
reduce inflammation and to determine the bioavailability of these compounds.
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Chapter 1: Introduction and Objectives
1.1 Introduction
Inflammation is the human body’s urgent response to tissue damage caused by chemicals,
physical injury, or pathogens (Weiss 2008). Inflammation occurs very often in humans because
humans are partly microbial and living in a microbial world, which results in countless
interactions with microbial stimuli and the possibility of tissue damage occurring (Nathan and
Ding 2010). The body’s first line of defense to this tissue damage is called the acute
inflammatory response, which is a non-specific response that mobilizes cells of the immune
system, including macrophages, monocytes and neutrophils (Kumar et al. 2004). In a normal,
healthy response, these immune cells arrive to the area of damage, activate the inflammatory
response, and initiate an immune response that usually results in removal of the stimulus and
healing of the tissue back to its’ normal functioning state (Liddiard 2011). When the acute
inflammatory response does not resolve, that is where problems arise. Non-resolving
inflammation, called chronic inflammation, is an extended, unregulated and maladaptive
response involving active inflammation, attempts at tissue repair, and tissue damage (Weiss
2008). Long-term low-grade chronic inflammation, noted by abnormally high levels of certain
markers in the circulation including C-reactive protein, tumor necrosis factor-a, and interleukin6, is a risk factor for several chronic diseases (Nicklas et al. 2005). Chronic inflammation does
not directly cause obesity, cancer, asthma, obstructive pulmonary disease, multiple sclerosis, or
rheumatoid arthritis, but it is known to significantly contribute to their and many other diseases’
pathogenesis (Nathan and Ding 2010). Destructive periodontal disease, which affects the tissues
surrounding and supporting the teeth, is another specific example of a disease involving
inflammation. These patients, presenting with swollen red gums, have elevated levels of the
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inflammatory mediators tumor necrosis factor-a and interleukin-6 (Khosravi et al. 2013).
Obesity is another example of a disease involving inflammation and is arguably the most
relevant to people in the United States. According to the most recent report by the Center for
Disease Control and Prevention an overwhelming 36.5% of United States adults are obese
(Ogden et al. 2015). The inflammation associated with obesity is caused by decreased insulin
sensitivity, increased intracellular stress, increased autophagy, hypoxia, and apoptosis, resulting
in the release of pro-inflammatory signals (Kloting and Bluher 2014).
Currently, several of the treatments for chronic inflammation include taking drugs such
as ibuprofen (Manish et al. 2003), drugs that inhibit the toll-like receptor pathway (Lucas and
Maes 2013) and use of immunocytokines (Bootz and Neri 2016). There are other types of
behavioral treatments, involving diet and exercise training, where the patients do not take any
drugs, but these are newer treatments and still an active area of investigation. Nicklas et al.
(2005) hypothesized that increased levels of adipose tissue contribute to chronic inflammation.
They summarized and reviewed 18 published studies on the topic and found that every study
concluded that dietary restriction leading to weight loss reduced markers of chronic
inflammation, including tumor necrosis factor-a, C-reactive protein, interleukin-6, interleukin-8,
interleukin-18, and others. Lee et al. (2013) corroborated that adipose tissue is an important
regulator of inflammation, releasing pro-inflammatory, TNF-a IL-1 IL-6 and IFN-g, and antiinflammatory cytokines, IL-4 IL-10 IL-3 and IL-Ra. They also stated that obesity, where a
person contains excessive amounts of adipose tissue, is an underlying condition for inflammatory
diseases (2013).
Diet is a critical factor in determining the level of adipose tissue, suggesting that diet
plays a role in inflammation. Other studies that look at the specific effects of diet on
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inflammation concluded that diets high in omega-3 fatty acids, fruits, nuts, vegetables, and whole
grains are associated with lower levels of inflammation generated by production of antiinflammatory cytokines, whereas diets high in refined starches, sugar, and fats are associated
with higher levels of inflammation generated by excessive production of pro-inflammatory
cytokines (Giugliano et al. 2006). Glisan et al. (2016) also noted that high fat diets were coupled
with increased toll-like receptor 4 expression and nuclear factor kB activation in monocytes,
which triggers the inflammatory response. New methods of prevention and treatment of
inflammation are an active area of investigation in the field, and the data from previous studies
strongly suggest that diet plays a role in inflammation (Nicklas et al. 2005) (Lee et al. 2013), and
that certain dietary factors can act as preventative or treatment methods to lower inflammation.
Fruits and vegetables have a variety of compounds associated with health benefits.
Cranberries (Vaccinium macrocarpon L) specifically, contain many bioactive compounds known
to improve urinary tract health, boost immune function, and reduce cardiovascular disease
(Kresty et al. 2011). Recent research also shows cranberries have potential anti-inflammatory
effects. In a study of hepatic inflammation in obese mice, cranberry polyphenol-rich extract
decreased inflammatory markers tumor necrosis factor-a and chemokine ligand 2 by 28% and
19% respectively (Glisan et al. 2016). The polyphenol-rich extract also decreased mRNA
expression in the liver of the toll-like receptor 4 and nuclear factor kB, which are important in
signaling pathways triggering inflammation, by 63% and 24% respectively, all over a period of
ten weeks (2016). A study by Anhe et al. (2015) also showed anti-inflammatory effects of
cranberry extract, specifically looking at the phenolic compounds, in high fat/high sucrose fed
mice. Results showing that the cranberry extract fully prevented diet-induced intestinal
inflammation in the mice by reducing COX2 activity and tumor necrosis factor-a. Both of the
3

aforementioned studies evaluated the cranberry extract for phenolic compounds, which likely
have a role in the anti-inflammatory action of the extracts, but it is quite possible that other
compounds in cranberries play a role in the berries’ anti-inflammatory effect. This possibility
presents the purpose of this study, to explore whether the volatile compounds in cranberries also
have anti-inflammatory properties. There has been very little research conducted specifically on
the anti-inflammatory properties of volatile compounds extracted from cranberries, but
previously conducted research suggests that volatile compounds overall have anti-inflammatory
and therapeutic potential due to their ability to suppress nuclear factor kB (Salminen et al. 2008).
Previous research also indicates that individual volatile compounds in cranberries can act as
possible anti-inflammatory agents. α-terpineol, which is the most abundant individual volatile
compound found in cranberries, has already shown the ability to inhibit the nuclear factor kB
pathway (Hassan et al. 2010). This previous evidence regarding volatile compounds and the most
abundant individual volatile compound in cranberries, α-terpineol, gives the hypothesis for the
current study encouraging potential, that cranberry volatile and phenolic compounds reduce
inflammation on RAW 264.7 cells, in vitro.
1.2 Objectives
Objective 1: Extract, quantify and identify the volatile and phenolic compounds in cranberries
via GC and HPLC methods.
Objective 2: Compare the anti-inflammatory effect of the volatile and phenolic extracts isolated
from cranberries on RAW 264.7 mouse macrophage cells.
Objective 3: Compare the anti-inflammatory effect of individual, more abundant volatile
compounds from cranberries (α-terpineol, eucalyptol, linalool oxide, and linalool) on RAW
264.7 mouse macrophage cells.
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Chapter 2: Literature Review
2.1 Phenolic Compounds
2.1.1 Functional Properties of Phenolic Compounds
Phenolic compounds are found in abundance in fruits, plants, herbs, vegetables, seeds,
roots, and leaves (Soto et al. 2015). In plants, the phenolics’ main role is to protect against stress,
but they also have a role in development, structural integrity and scaffolding, and plants’ ability
to adapt to changing environments (Bhattacharya et al. 2010). Phenolic compounds are
secondary plant metabolites, produced in response to stressors such as ultraviolet radiation,
ozone, pollution, infection by pathogens, extreme temperature exposure, and tissue damage (Soto
et al. 2015). Phenolics also contribute to the color, taste, and putative health promoting benefits
associated with the plant producing them (Boudet 2007). Phenolic esters play a role in
strengthening the cell wall of plants, giving texture to plant foods, and contributing to plant
disease resistant properties (Beveridge et al. 2000) (Parr et al. 1997). The total amount of
phenolic compounds found in a particular plant depends on factors such as growing conditions,
cultivation techniques, cultivar, ripening processes, storage conditions, and others, and the
phenolic content may change, increasing under the stressful conditions previously mentioned
(Soto et al. 2015).
2.1.2 Classification of Phenolic Compounds by Chemical Structure
Phenolic compounds contain one or more aromatic rings and one or more hydroxyl
substituents by definition. These compounds are usually not found as free compounds
(aglycones), they are most commonly esters, glycosides, or methyl esters (Soto et al. 2015). A
“simple phenol” is a phenolic compound containing one aromatic ring, whereas a “polyphenol”

5

contains multiple aromatic rings, and the two groups can be further classified by their side chain
groups.
Phenolic compounds can be formed through two different pathways, the acetic acid
pathway and the shikimic acid pathway, forming mainly simple phenols and phenylpropanoids
respectively (Soto et al. 2015). The “simple phenols” group can be further broken down into two
groups, coumarins and phenolic acids. Coumarins are formed by the cyclization of o-coumaric
acid and are glycosides. The phenolic acids contain one aromatic ring and a carboxylic acid side
chain and they, along with their derivatives, are known for being native antioxidants (Koroleva et
al. 2014). Caffeic acid, a specific phenolic acid derivative, is one of the most prevalent phenolic
acids found in fruits and vegetables (Ghulam et al. 2014).
2.1.3 Bioavailability of Phenolic Compounds
Phenolic compounds have been extensively studied in vitro, but it is still questioned how
and whether the effects seen in in vitro translate in vivo. The most common phenolic compounds
in nature are phenolic acids and flavonoids therefore the bioavailability of phenolic compounds
can be split into groups, phenolic acids and flavonoids (Karakaya 2010). Ferulic, sinapic, pcoumaric, and caffeic acids are all hydroxycinnamic acids, which is a subclass of phenolic acids,
and have been found to have 25% absorption in the foregut after two hr, with a suggested
mechanism of Na+ dependent carrier-mediated transport for absorption (Wolffram et al. 1995). In
another study with rats fed specifically a ferulic acid rich diet, 45-53% of the dose was reported
available for peripheral tissues, and a proportion between urinary excretion of ferulic acid and
ferulic acid dose was determined, leading to the conclusion that the compound was highly
absorbed (Adam et al. 2002). However, it was determined that the when the ferulic acid was in a
food with a complex matrix, such as a cereal, there was lower absorption of the compound
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(Adam et al. 2002). The bioavailability of flavonoids used to be believed as negligible due to
being bound to glycosides, and that only aglycones could pass into the bloodstream from the gut,
however, now several studies have demonstrated that specific flavonoids have a much higher
bioavailability than previously thought. Quercetin has been reported at 62% dose absorption in
the bile twenty minutes after ingestion in Wistar rats (Crespy et al. 2002). In a human study by
Hollman et al. (1995), orally administered quercetin absorption was approximately 24% and the
absorption of quercetin glycosides from onions, which were previously thought to be negligible,
was 52%.
2.2 Volatile Compounds
2.2.1 Functional Properties of Volatile Compounds
Volatiles are called “volatile” because they can be easily vaporized at ambient
temperature. At ambient temperature they have a very low boiling point, or high vapor pressure.
Fruits and vegetables produce a wide range of volatile compounds that make up their aroma, add
to their flavor, and indicate the quality of the flavor (El Hadi et al. 2013). Although many of the
same specific individual volatile compounds are found in different fruits and vegetables, it is the
mixture of the volatile compounds that gives each fruit or vegetable its distinctive aroma (Tucker
1993). Volatile compounds also serve as a defense mechanism against insect feeding in plants. In
response to mechanical damage, the compounds are synthesized and released to ward off insects
(Pare and Tumlinson 1999). There are several different factors that affect the volatile
composition of a fruit or vegetable, including degree of maturity, genetic makeup, postharvest
handling and storage, and environmental conditions (El Hadi et al. 2013).
Volatile compounds are synthesized as secondary metabolites in fruits and vegetables,
they are formed due to enzymatic activity when the tissue is disrupted due to cutting and
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shredding (Gary 1999). For example, when chopping an onion, the smell is not very noticeable
until the onion is sliced open, i.e. the tissue is disturbed, and the volatile compounds are formed
and released. The volatiles important for the aroma and flavor of fruits and vegetables are
biosynthesized from the following precursors: membrane lipids, amino acids, and carbohydrates
(Sanz et al. 1997).
2.2.2 Classification of Volatile Compounds by Chemical Structure
Biosynthetic pathways for the synthesis of volatile compounds can begin with fatty acids,
amino acids, carotenoids, and terpenoids. Terpenoids are the largest class of secondary plant
metabolites and are just one of the groups contributing to the total volatile profile. They consist
of one or more isoprene units forming a hydrocarbon chain, and several variations including
oxygenated, acyclic, monocyclic, and bicyclic exist. Terpenoids are commonly broken down into
classes by the number of isoprene units in their structure. Hemiterpenoids (1 isoprene unit and 5
carbon atoms), monoterpoids (2 isoprene units and 10 carbon atoms), sesquiterpoids (3 isoprene
units and 15 carbon atoms), homoterpoids (2 and 3 isoprene units and 11 and 16 carbon atoms
respectively) and a few diterpenoids (4 isoprene units and 20 carbon atoms) are the volatile
terpenoids that have very high vapor pressure and can be released into the atmosphere (El Hadi
et al. 2013).
2.2.3 Biosynthesis of Volatile Compounds
Volatile compounds are synthesized from isopentenyl diphosphate (IPP), a universal 5
carbon precursor, and dimethylallyl diphosphate (DMAPP), IPP’s allylic isomer (El Hadi et al.
2013). These two precursors can be produced via two different pathways in plants, the
deoxyxylulose phosphate pathway, also called the mevalonate independent pathway, and the
mevalonate pathway (McGarvey and Croteau 1995). The mevalonate pathway (MVA pathway)

8

occurs in the cytosol and starts with the condensation of an acetyl coenzyme A unit to an active
isoprene unit (IPP) (Newman and Chappell 1999). The mevalonate independent pathway (MEP
pathway) occurs in the cell plastids and forms IPP and DMAPP from pyruvate and
glyceraldehyde 3-phosphate and uses methylerythritol phosphate (MEP), as the key intermediate
(Lichtenthaler 1999).
After IPP and DMAPP are formed via these two pathways, IPP and DMAPP are
combined in different ratios and acted upon by enzymes to create the precursors to the final
volatile compound. A specific example of this is two molecules of IPP and one molecule of
DMAPP being condensed in the cytosol, catalyzed by farnesyl pyrophosphate synthetase (FFPS)
to produce farnesyl pyrophosphate, which is the natural precursor of sesquiterpenoids
(McGarvey and Croteau 1995).
2.3 Phenolic Compounds and Volatile Compounds in Cranberries
2.3.1 Phenolic Compounds in Cranberries
Cranberries are a rich source of phenolic compounds containing flavonoid compounds
such as flavan-3-ols/flavonols/anthocyanins, and phenolic acids such as hydroxybenzoic acid and
hydroxycinnamic acids, along with their derivatives (Sanchez-Patan et al. 2012). The total
phenolic makeup of cranberries contains approximately 20-25 individual phenolic compounds
(Wang and Zuo 2011). The exact number of different individual phenolic compounds in
cranberries vary in the literature, but hydroxybenzoic acid/ hydroxybenzoic acid derivatives,
quercetin, and myricetin have been found by multiple studies to be the most prevalent phenolic
compounds, and o-hydroxcinnamic acid, p-coumaric acid, caffeic acid, ferulic acids, and
epicatechin are present in moderate amounts (Wang and Zuo 2011) (Nowak et al. 2016). Fresh
cranberries have also been found to have higher total phenolic levels (12.4 mg/g) than products
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like cranberry juice (9.1 mg/g) and cranberry sauces (11.1 mg/g) (Want and Zuo 2011). This has
posed as an important factor to consider for studies involving the effects of intake of cranberry
phenolic compounds because fresh cranberries have an astringent and sour taste.
2.3.2 Volatile Compounds in Cranberries
Cranberry volatiles constitute several different types of compounds including aromatic
compounds, terpenes, alcohols, and aldehydes (Croteau and Fagerson 1968). The aromatic
compounds (benzaldehyde/benzyl/benzoate esters) and terpenes (α-terpineol) appear to be the
major contributors to cranberry aroma, contributing to 40% and 17% of the total volatile fraction
respectively in the study by Croteau and Fagerson (1968). Croteau and Fagerson also found that
the terpene, α-terpineol, was the most abundant cranberry volatile, individually making up 13.6%
of the total volatile fraction (1968). The study by Hirvi et al. (1981) mirrored these results,
reporting aromatic compounds and terpenes making up 34% and 19% respectively, and αterpineol individually making up 10% of the total volatile fraction. A third study by Anjou and
Von Sydow (1967) found the aromatic compounds and terpenes made up 31% and 40%
respectively and individual α-terpineol 23.7% of the total volatile fraction. The percentages of
individual volatiles in cranberries varies in the literature, but all the literature concludes that
aromatic compounds and terpenes contribute the largest amounts to the total volatile fraction,
and α-terpineol is individually the most abundant volatile in cranberries.
2.4 Cranberry Consumption and Cranberry Health Benefits
2.4.1 Cranberry Consumption
According to the most recent report published by the United States Department of
Agriculture, National Agriculture Statistics Service (NASS), the total amount of fresh
cranberries consumed per person, per year, is 0.08 pounds (USDA, National Agriculture
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Statistics Service 2014). Only these very small amounts of fresh cranberries are consumed likely
due to the elevated hydroxybenzoic acid and proanthocyanin contents, which gives cranberries a
very strong and astringent taste making them unacceptable to most palates in large amounts (Nile
and Park 2014). Cranberry products, such as dried cranberries, cranberry juices, and cranberry
sauces, even though they have lower total levels of bioactive compounds, are much more
practical ways to consume cranberries due to addition of sugar to the products.
2.4.2 Cranberry Health Benefits
Several health benefits have been attributed to cranberry consumption including
prevention of urinary tract infections, disruption of oral pathogen virulence and biofilm
formation, modulation of the inflammatory response, and promotion of cardiovascular health
(Pappas and Schaich 2009). Cranberries have also shown potential inhibiting effects on
degenerative diseases including Alzheimer’s and cancer (Pappas and Schaich 2009).
Prevention of urinary tract infections is the most extensively researched health benefit of
cranberries. Urinary tract infections, in 75-95% of cases, are caused by the Escherichia coli
pathogen adhering to the epithelial cells of the urinary tract, and the high acid content of
cranberries prevents this adhesion to prevent infection (Zafrifri et al. 1989). Although it is now
well accepted that cranberries aid in the prevention of urinary tract infections, the specific
compounds in the cranberries that yield these protective properties are still up for debate.
Cranberries have been associated with dental health by reducing bacteria in the mouth
and preventing plaque biofilm formation. The two main bacteria in the mouth responsible for
dental caries are Streptococcus mutans and Streptococcus sobrinus. When these bacteria coaggregate, they form biofilms and release acids that decay the teeth. Weiss et al. (1998) found
that cranberry juice inhibited the co-aggregation of these bacteria in 58% of samples tested.
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Other studies later confirmed that cranberry juice inhibited co-aggregation and biofilm
formation, associating them with possible oral health benefits, but only if the cranberry juice was
not supplemented with sugar (Bodet et al. 2006) (Wiess et al. 2002) (Steinberg et al. 2005). The
in vivo evidence for cranberries’ contribution to oral health is limited, but toothpastes or
mouthwashes supplemented with cranberry phytochemicals appear to be promising.
Recent research also shows potential for cranberries to inhibit cancer cell growth. In a
study by Seeram et al. (2006) cranberry extracts showed the ability to inhibit cancer cell growth,
with higher concentrations of the extracts having a higher inhibitory effect in all of the tumor cell
lines tested, which included oral, breast, colon, and prostate cancers. In 5 out of the 6 cell lines
studied, the cranberry extract showed a significant inhibitory effect. Cranberry had the second
lowest IC50 value for the MCF-breast cancer cell line and the fourth lowest IC50 value for the
CAL-2-oral cancer cell line, indicating that the cranberry extract was a very potent growth
inhibitor in these two cases (Seeram et al. 2006).
Consumption of cranberries is also suggested to play a role in cardiovascular health and
neurological disease by decreasing the inflammatory response and increasing the antioxidant
capacity in human plasma (Pappas and Schaich 2009).
2.5 Cranberry Anti-inflammatory Properties
2.5.1 Cranberry Phenolic Compounds Anti-inflammatory Activity
During inflammation, cells are faced with oxidative stress. Reactive oxygen species
(ROS) are produced and considered one of the most potent stimuli for inflammation because they
also stimulate the immune system monocytes/macrophages and increase the production of proinflammatory cytokines TNF- α, IL-8, IL-6 and IL-1b (Sultana and Saify 2012). Cranberry
extracts have shown the ability to decrease the production of these reactive oxygen species and
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pro-inflammatory cytokines. In the study by Mathison et al. (2014) subjects consumed acute
doses of cranberry beverages. Blood was collected at 2-hr intervals from 0 to 8 hr and 24 hr after
treatment and the biomarkers of antioxidant status were lower compared to starting values.
In the study by Bodet et al. (2006) macrophage cells were treated with a cranberry
phenolic fraction before stimulation with lipopolysaccharide (LPS), another potent inducer of
inflammation. After treatments with the cranberry fraction and LPS, the inflammatory markers
TNF- α, IL-8, IL-6 and IL-1b were compared to positive and negative controls. The cranberry
treated cells exhibited much lower levels, indicating that the cranberry fraction was a potent
inhibitor of the pro-inflammatory responses induced by LPS.
2.5.2 Cranberry Volatile Compounds Anti-inflammatory Activity
There has been very little research conducted specifically on the anti-inflammatory
properties of volatile compounds extracted from cranberries, hence the reason for this study, but
total cranberry fractions have shown potent anti-inflammatory activity. Previously conducted
research suggests that volatile compounds overall have anti-inflammatory and therapeutic
potential due to their ability to suppress nuclear factor kB, a factor that controls transcription of
DNA to produce the pro-inflammatory cytokines (Salminen et al. 2008). Previous research also
indicates that individual volatile terpenoids in cranberries can act as possible anti-inflammatory
agents. α-terpineol, which is by far the most abundant individual volatile compound in
cranberries, has already shown the ability to inhibit the nuclear factor kB pathway (Hassan et al.
2010), thus suggesting it and possibly other individual volatile terpenoids in cranberries could
play a role in the berries’ anti-inflammatory action.
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Chapter 3: Extraction, Quantification, Identification, and Free Radical-Scavenging
Activity of Cranberry Phenolic Compounds
3.1 Introduction
In the literature regarding cranberries, the cranberry phenolic compounds have been
suggested to be responsible for the majority of the berries’ beneficial health properties, including
their anti-inflammatory activity. This study took a different approach, suspecting other
compounds may also contribute to cranberries’ anti-inflammatory effect. The hypothesis of this
study was that the volatile compounds, and not just the previously hypothesized phenolic
compounds, also have anti-inflammatory capabilities when tested in vitro on RAW 264.7 cells.
For this study, it was necessary to evaluate the cranberry phenolic extract for its in vitro antiinflammatory effect on RAW 264.7 cells to be able to compare its effect to the effect of the
volatile extract. At the time of this study, the phenolic compounds have been deemed to be the
major bioactive source of cranberry’s anti-inflammatory properties (La et al. 2010).
Most methods recommend using a mixture of organic solvents and polar solvents to
extract phenolic compounds, especially for berries high in anthocyanin content like a cranberry
(La et al. 2010). These recommendations were followed and used to extract the phenolic
compounds for this study and are explained in section 3.3.1.
3.2 Materials
Cranberries (Stahlbush Island Farm brand) were purchased from Harps Foods,
Fayetteville, AR. Stahlbush Island Farm is located on 5000 acres of land in the Willamette
Valley of Oregon. The cranberries farmed there are left in the field until ripe, and frozen
immediately after harvest to seal in flavor and freshness. After purchase from Harps Foods, the
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cranberries were stored unopened and frozen at -20° C until used for experimentation to avoid
any degradation of the phenolic compounds.
3.3 Methods
3.3.1 Extraction of Phenolic Compounds
Cranberries were thawed to room temperature and rinsed with running water to remove
any dirt/debris. Three separate phenolic extracts were prepared from fresh cranberries.
Approximately 100 g of the rinsed cranberries were homogenized with 250 mL methanol, water,
and formic acid using a Euro Turrax T18 Tissuemizer (Tekmar-Dohrman Corporation, Mason,
OH) for approximately 60 sec. The homogenate was then vacuum filtered through Miracloth
(CalBioche, LaJolla, CA) and the resulting filtrate was collected. The resulting residue was
homogenized using the Euro Turrax Tissuemizer with 250 mL of acetic acid, water and acetone
for approximately 60 sec. The residue homogenate was vacuum filtered through Miracloth and
combined with the previously collected filtrate. That resulting residue was homogenized, and
vacuum filtered the same as the previous residue. The final residue and Miracloth were rinsed
with both solvents, methanol/water/formic acid and acetic acid/water/acetone to collect any
remaining cranberry compounds and added to the final filtrate. The final filtrate was placed in a
Buchi Rotary Evaporator R-114 (Buchi, Flawil, Switzerland) set at 40°C to evaporate all of the
solvents leaving only the phenolic extract. Next, the phenolic extract was centrifuged for 5 min
at 10,000 rpm and supernatant collected. The extract was then loaded onto a Sep-Pak® C18
column cartridge (Waters Corporation, Milford, MA) and eluted with 70-100% ethanol until
color was no longer visible in the cartridges. The samples were passed through 0.45 µm filters
(Whatman) before HPLC analysis.

15

3.3.2 High-Performance Liquid Chromatography (HPLC) Analysis of Phenolic Compounds
The individual phenolic compounds from the cranberry extract were separated by HPLC
on a 250 X 4.60 mm Symmetry 5 µm C18 column (Waters Corp, Milford, MA). The resulting
peaks were analyzed at 320, 360, and 510 nm using a Waters Model 996 photodiode array
detector (Waters Corp, Milford, MA). Each sample injection volume was 100 µL. Solvent A was
the mobile phase, water acidified with phosphoric acid to pH 2.6 and methanol was used as
solvent B. The flow rate was 1.33 mL/min, and a gradient of the solvents was used to get the best
separation of the compounds, starting with 88% A from 0-10 minutes, 85% A from 10-26
minutes, 40% A from 26-55 minutes, 30% A from 55-70 minutes, and 88% A from 70-85
minutes. Detection wavelengths of 320, 360, and 510 nm was used to monitor hydroxycinnamic
acids, flavonols and anthocyanins, respectively. Individual anthocyanin monoglucosides and
acylated anthocyanin derivatives were quantified as Cyd (cyanidin), Pnd (peonidin), and Mvd
(malvidin) glucoside equivalents using external calibration curves of a mix of the three
anthocyanin glucosides. Anthocyanins were quantified as a mixture of these glucosides because
they are naturally occurring common anthocyanidins found in nature. Hydroxycinnamic acids
were quantified as chlorogenic acid equivalents using external calibration curves of chlorogenic
acid and flavonols were quantified as rutin equivalents using external calibration curves of rutin.
Results are expressed as mg of anthocyanin-3-glucoside equivalents, chlorogenic acid
equivalents, and rutin equivalents per kg of fresh weight.
3.3.3 Total Phenolic Content
The total phenolic content of the phenolic extract was measured using the Folin-Ciocalteu
assay. First, 0.5 mL of 0.2 N Folin-Ciocalteu reagent was mixed with 0.1 mL of the cranberry
phenolic extract. Next, 0.4 mL of 7.5% NaHCO3 was added and mixed into the solution. The
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solution was then placed into a 48-well plate in triplicate and let sit in the dark for 2 hr at room
temperature. After the 2 hr, the absorbance of each sample was read at 760 nm. Total phenolic
quantification was determined by comparing the absorbances of the samples to the absorbances
of known gallic acid equivalents (GAE) at 100, 50, 25, 12.5, 6.25, and 3.125 mg per kg, which
were prepared in the same way as the samples. Results are expressed as averages of each
triplicate, with units of mg of GAE per kg fresh weight.
3.3.4 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Assay
Total procyanidins present in the phenolic extract was measured using the DMAC assay
following the methods of Payne et al. (2010). A solution of 3 mL of HCl in 27 mL alcohol was
prepared and then 0.03 g of DMAC was added to the solution (now be referred to as DMAC
solution). Aliquots (50 µL) of blanks, standards, and extracts were prepared. 250 µL of DMAC
solution was added to all prepared blanks, standards, extracts. Plate was read immediately at 640
nm. Catechin was used as the standard (2, 4, 8, 16, 32, and 64 mg/kg) with results expressed as
mg of catechin equivalents per kg fresh weight.
3.3.5 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Assay of Phenolic
Extract
Total antioxidant capacity of the phenolic extract was measured using a modified DPPH
method published by Akkari et al. (2016). 1.4 mL of a solution of DPPH in methanol was added
to 0.1 mL of the phenolic extract at 10x, 20x, 40x, 80x, and 160x dilutions. The combined
solution sat in the dark for 30 minutes, then absorbance on a spectrophotometer at 517 nm was
measured. Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) was used as the
standard (50, 100, 200, 400, 800 µM) with results expressed as µM of Trolox per kg of sample.
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3.4 Results
3.4.1 HPLC
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Figure 3.1 HPLC chromatogram at 360 nm measuring for flavonols
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Figure 3.2 HPLC chromatogram at 510 nm measuring for anthocyanins
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Table 3.1 Composition of anthocyanins, flavonols, and hydroxycinnamic acids in cranberry
extract
Hydroxycinnamic acids (mg
Anthocyanins (mg ACY-3Flavonols (mg Rutin
Chlorogenic acid equiv./kg
Glu equiv. /kg FW)
equiv./kg FW)
FW)
Cyd-3-gal

148.0±1.0

Myr-3-pentoside

6.7±0.0

Cyd-3-glu

2.7±0.0

Myr-3-pentoside
Quer-3-xylo

0.7±0.0
3.4±0.0

Cyd-3-arab
Mal-3-gal

93.1±1.0
8.0±2.0

Quer-3arbinopyranoside
Myr-3-gal

9.2±0.0
17.4±0.0

Peo-3-gal

489.8±4.0

Peo-3-arab

195.0±2.0

Chlorogenic acid

14.7±0.0

Quer-3arabinofuranoside 3.4±0.0
Quer-3-gal
25.5±0.0
Quer-3-glu
2.7±0.0
Quer-3-rham
Isorham-3hexoside
Isorham-3pentoside
Isorham-3pentoside
Isorham-3pentoside
Isorham-3pentoside
Quer-3-benzoylgal

2.7±0.0
2.7±0.0
5.4±0.1
0.7±0.0
1.3±0.0
1.3±0.0
0.7±0.0

Total
Total
Hydroxycinnamic
Anthocyanins
936.6±8.0
Total Flavonols 84.4±1.0 acids
14.7±0.0
Anthocyanins were quantified using an external calibration curve of a mix of the three
predominant anthocyanin glucosides found in cranberries; Cyd (cyanidin), Pnd (peonidin), and
Mvd (malvidin) glucoside equivalents per kg of fresh weight. Flavonols were quantified using an
external calibration curve of rutin and are expressed as mg of rutin equivalents per kg of fresh
weight. Hydroxycinnamic acids were quantified using a chlorogenic acid external calibration
curve and are expressed as mg of chlorogenic acid equivalents per kg of fresh weight.
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3.4.2 Total Phenolic Content Using Folin-Ciocalteu Assay
Table 3.2 Total phenolic content of cranberry extract

Cranberry phenolics
Cranberry phenolics
Cranberry phenolics

abs 760 nm
0.3593
0.3700
0.3760

extract
dilution
0.67
0.67
0.67

assay
dilution
50
50
50

Total Phenolics
1240
1277
1297
Average 1271

Total Phenolics are expressed as the triplicate average with units of mg of gallic acid equivalents
(GAE) per kg fresh weight.
3.4.3 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Assay
Table 3.3 Summary statistics of DMAC analysis of phenolic extract
Mean

323.6

Std Dev

12.7

Std Err Mean

3.0

Upper 95% Mean

329.9

Lower 95% Mean

317.4

N

3
Total procyanidins

323.6 mg/kg+/-2.9 SEM
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3.4.4 DPPH (2,2-diphenyl-1-picrylhydrazyl) Free Radical-Scavenging Assay of Phenolic
Extract
Table 3.4 Summary statistics of DPPH analysis of phenolic extract.
Mean

4676.4

Std Dev

230.0

Std Err Mean
Upper 95% Mean

93.9
4917.7

Lower 95% Mean

4435.1

N

3
Total Antioxidant Capacity 4676.4 µM/kg+/-93.9

3.5 Discussion
3.5.1 HPLC Analysis Discussion
HPLC analysis was used to determine the composition of the anthocyanins, flavonols,
and hydroxycinnamic acids (a subcategory of phenolic acids) present in the phenolic extract. In
this analysis, there were seven different anthocyanin compounds present, with total anthocyanins
equaling 936.6 ± 8.0 mg ACY-3-glucoside equiv. per kg fresh weight, sixteen different flavonol
compounds present, with total flavonols equaling 84.4 ± 1.0 mg rutin equiv. per kg fresh weight,
and one hydroxycinnamic acid identified, with total hydroxycinnamic acids equaling 14.7 ± 0.0
mg chlorogenic acid equiv. per kg fresh weight (Table 3.1). It appears that the cranberry phenolic
profile has been well mapped, because the literature is in agreeance with the results of this study.
Although some studies reported results on dry weight basis instead of fresh weight, all studies
reported the highest concentration of classes of compounds to be the proanthocyanidins and
anthocyanins, at 133 g per kg dry weight and Wu et al. (2006) only looked specifically at total
anthocyanin content and reported a value of 1400 ± 28.5 mg per kg of fresh weight, which is
comparable to the 936.6 ± 0.8 mg per kg of fresh weight found in this study. One thing that did
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seem to differ among the literature was the number of compounds identified in the cranberry
phenolic fraction, found to be twenty-three in this study and reported at seventeen and eleven in
others (Seeram et al. 2006, Gregoire et al. 2007). In the study that reported only eleven highly
purified compounds by using HPLC analysis to separate flavonols, phenolic acids, and
proanthocyanins of cranberries they identified the following; quercetin, quercetin-3-glucoside,
quercetin-3-galactoside, quercetin-3-arabinofuranoside, quercetin-3-rhamnoside, myricetin,
myricetin-3-rhamnoside, epicatechin, epicatechin-(4b-8)-epicatechin, caffeic acid, and
chlorogenic acid (Gregoire et al. 2007), and two of those were not identified in this study.
Differences were likely due to differences in analytical procedures. Three different wavelengths
were monitored to identify the anthocyanins, flavonols, and hydroxycinnamic acids in this study,
whereas Gregoire et al. (2007) did not report the wavelength(s) used to identify the compounds.
The differences among the two studies could also be due to analysis of different cranberry
varieties.
3.5.2 Total Phenolics by Folin-Ciocalteu Discussion
The total phenolic content of the cranberry extract used in this study was 1271 mg GAE
per kg fresh weight, shown in Table 3.2. Upon comparison to other studies analyzing cranberry
extract for total phenolics, results seem to vary. The 1271 mg GAE per kg fresh weight found in
this study is low compared to the 1627 mg GAE per kg of fresh weight reported by Nowak et al.
(2016). Results of this study also seem low compared to the study by Abeywickrama et al.
(2016), who reported the total phenolics of market-mature cranberries to be ~6100 mg GAE per
100 g dry weight. Due to the different nature of the method (fresh weight vs. dry weight) it is
expected that the dry weight would be much higher because of concentration of the phenolic
compounds during the drying process. The cranberries used in these studies could also be
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different varieties or cultivated in different methods resulting in the differing values for total
phenolic content.
3.5.3 DMAC (4-dimethylaminocinnamaldehyde) Total Procyanidins Discussion
Total procyanidins of the cranberry extract used in this study were found to be 324
mg/kg. The literature reports greatly varying values, Wallace and Giusti (2010) evaluated eight
different cranberry samples and found total procyanidins varying from 780 to 22,450 mg per kg.
Another study found total procyanidins of cranberry extract to be 5 mg per kg, total procyanidins
of whole cranberries to be 17 mg per kg, and total procyanidins of two cranberry juices to be 223
and 216 mg per kg (Prior et al. 2001). The large variation in total procyanidins reported in the
literature and found in this study could be due to different starting cranberry products (different
varieties of fresh cranberries, freeze dried cranberries, cranberry juices ect.) and different
extraction and analytical methods used for quantification.
3.5.4 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Discussion
Total antioxidant capacity of the phenolic extract used in this study was found to be 4,676
µM Trolox per kg. In the literature, using the oxygen radical absorbance capacity assay (OREC)
cranberry anti-oxidant capacity has been reported as high as 95,840 µM Trolox equivalent per kg
and ranked number one among fifty fruits and vegetables evaluated (Floegel et al. 2011),
however different methods to evaluate total antioxidant capacity yield different results. The
DPPH method in Floegel et al. (2011) study reported antioxidant capacity at 868 mg vitamin C
equivalents per kg fresh weight, which is high compared to the other fruits and vegetables tested,
but hard to directly compare to this study as Trolox is a vitamin E derivative. Borowska et al.
(2009) reported the antioxidant capacity of wild cranberry to be 36,900 µM Trolox per kg and
Wang and Stretch (2001) reported 8,200 – 10,100 µM Trolox per kg in their study. The large
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variation of antioxidant capacity found in this study and in the literature is likely due to differing
cranberry varieties, different cultivar techniques, different cranberry starting products, and
different extraction and quantification methods.
Chapter 4: Extraction, Quantification, Identification and Free Radical-Scavenging Activity
of Cranberry Volatile Compounds
4.1 Introduction
To discover whether the volatile compounds in cranberries also have an antiinflammatory effect, the volatile compounds from the cranberries needed to be extracted for in
vitro experimentation on the RAW 264.7 cells. The volatile extract also was further analyzed
using Gas Chromatography – Mass Spectrometry (GC-MS) to determine which individual
volatile compounds were present. Due to the instability of volatile compounds at high
temperatures, vacuum distillation followed by rapid cooling, to avoid any degradation, was used
for isolation of the individual volatiles (Belitz et al. 2009).
4.2 Materials
Cranberries (Stahlbush Island Farm brand) were purchased from Harps Foods,
Fayetteville, AR. Stahlbush Island Farm is located on 5000 acres of land in the Willamette
Valley of Oregon. The cranberries farmed there are left in the field until ripe, and frozen
immediately after harvest to seal in flavor and freshness. After purchase from Harps Foods, the
cranberries were stored unopened and frozen at -20° C until used for experimentation to avoid
any degradation of the volatile compounds.
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4.3 Methods
4.3.1 Extraction of Volatile Compounds
Cranberries were thawed to room temperature and rinsed with running water to remove
dirt and debris. Three separate volatile extracts were prepared from fresh cranberries. Volatiles
were obtained by combining 300 g of berries, 300 mL deionized water, and 100 g NaCl and
blending for one min in a Waring blender. The homogenate was vacuum distilled at 28 in. Hg,
50°C water bath, 0oC condenser for 30 min using a Buchi rotary evaporator (Buchi, Flawil,
Switzerland). The first 200 mL was collected in a flask contained in an ice water bath. Additional
ice packs were strapped to the condenser to aid in condensation and collection of volatiles. The
final collected cranberry extract was put in a glass jar, sealed, and immediately stored in the
freezer at -20 ºC until used for experimentation.
4.3.2 Solid Phase Micro-extraction (SPME) of Volatiles
An 85µm, CAR/PDMS, Stableflex, 24 Ga, Manual Supelco (Bellefonte, PA) SPME fiber
was used in this study. Vials containing 4 mL of volatile extract were placed on a stir plate with
temperature set at 65° C with the SPME fiber inserted into the headspace above the sample.
Adsorption was timed for 30 min. Samples of volatiles (100 µL) were placed into 1 mL vials.
After preheating for 5 min at 40oC, headspace volatiles were collected by SPME for 20 min at
60oC using a DVB/CAR/PDMS fiber (Supleco Inc., Bellafonte, PA).
4.3.3 GC Quantification of Volatiles
Volatiles adsorbed to the SPME fibers were desorbed at 270 °C for 2 min in the injection
port of a Varian 3800 GC (Agilent Technologies, Santa Clara, CA) equipped with a HP-5 (5%
phenyl-methylpolysiloxane) column (30 m X 250 um X 1 um) (Agilent Technologies, Santa
Clara, CA). The FID detector was at 280°C. GC runs were 29 min, and the fiber remained in the
25

injection port for 10 min after each run. The injection port was operated in splitless mode with a
constant He flow of 25 psi. The initial oven temperature was 25° C, held for 4 min, ramped up at
12 °C/ min to 289° C, and held at for 3 min. Volatiles were quantified as heptanal, octanal, alpha
phellandrene, d-limonene, limonene, ocimene, nonanal, terpin-4-ol, alpha terpineol, beta
caryophyllene, and alpha caryophyllene.
4.3.4 GC-MS Identification of Volatiles
SPME-collected volatiles were analyzed by GC-MS using a Hewlett-Packard HP 5890
series gas chromatograph equipped with a mass selective detector (MSD) and a HP-5 capillary
column (Agilent, 30 m x 0.25 mm, film thickness 1 µm). Working conditions included: injector
temperature 270oC; MSD interface temperature 280oC; oven temperature programmed from 10oC (1 min) to 280oC at 12oC/min; carrier gas (He) at a flow rate of 0.78 mL/min; injection port
operated in splitless mode. MSD acquisition parameters included full scan mode, scan range 20300 m/z and scan speed 3.2 scans/s. Volatiles were identified by comparing their mass spectra
with the spectral library (Wiley7NIST0.5), literature data, and alkane retention indices C5-C20.
4.3.5 Total Phenolic Content
The total phenolic content of the volatile extract was measured using the Folin-Ciocalteu
assay. First, 0.5 mL of 0.2 N Folin-Ciocalteu reagent was mixed with 0.1 mL of the cranberry
volatile extract. Next, 0.4 mL of 7.5% NaHCO3 was added and mixed into the solution. The
solution was then placed into a 48-well plate in triplicate and let sit in the dark for 2 hr at room
temperature. After the 2 hr, the absorbance of each sample was read at 760 nm. Total phenolic
quantification was determined by comparing the absorbances of the samples to the absorbances
of known gallic acid equivalents (GAE), which were prepared in the same way as the samples.
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Results are expressed as averages of each triplicate, with units of mg of GAE per 100 g fresh
weight.
4.3.6 DPPH (2,2-diphenyl-1-picrylhydrazyl) Total Antioxidant Capacity Assay of Volatile
Extract
Total antioxidant capacity of the phenolic extract was measured using a modified DPPH
method published by Akkari et al. (2016). 1.4 mL of a solution of DPPH in methanol was added
to 0.1 mL of the phenolic extract at 10x, 20x, 40x, 80x, and 160x dilutions. The combined
solution sat in the dark for 30 minutes, then absorbance on a spectrophotometer at 517 nm was
measured. Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) was used as the
standard (50, 100, 200, 400, 600, 800 µM) with results expressed as µM of Trolox per Kg of
sample.
4.4 Results

Figure 4.1 GC-MS Chromatogram of cranberry volatiles.
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Table 4.1 Composition of cranberry volatiles using GC-MS
Retention Time1 (min)
Volatile Compound
4.22
1-Butanol
8.12
1-Pentanol
9.1
Hexanol
11.97
Heptanal
13.65
1-heptanal
13.45
Benzaldehyde
13.87
1-octen-3-ol
14.4
Octanal
14.57
Alpha phellandrene
14.98
D-limonene
15.06
Limonene
15.17
Eucalyptol
15.21
Ocimene
15.36
Ocimene
15.63
2-octanal
15.88
Linalool oxide
16.35
Linalool
16.5
Nonanal
16.58
Nd
18.09
Terpin-4-ol
18.45
Alpha terpineol
19.46
Carvone
19.61
Trans-2-decanal
22.59
Beta caryophyllene
23.21
Alpha caryophellene
Total Volatiles
Nd, not determined.
1
Retention times correspond to retention times in Figure 4.2.

Concentration (ppb)
18.19
24.58
24.73
6.78
14.64
17.94
16.85
10.87
27.17
22.66
4.20
189.04
40.25
7.76
110.26
224.42
41.32
15.46
46.73
74.36
2320.55
45.85
134.20
54.68
58.00
3551.5

The results of the Folin-Ciocalteu assay measuring for total phenolics of the cranberry volatile
extract was zero, as expected.
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Table 4.2 Summary statistics of DPPH analysis of volatile extract.
Mean

40.2

Std Dev

1.8

Std Err Mean

0.72

Upper 95% Mean

42.0

Lower 95% Mean

38.3

N

6
Total Antioxidant Capacity 40.2 µM/Kg+/-0.72 SEM

4.5 Discussion
The chromatogram from Figures 4.1 contain a large number of peaks, which displays the
complex aromatic composition of cranberries. 25 individual volatile compounds in the cranberry
volatile extract used for this study were identified using Mass Spectrometry analysis and are
listed in Table 4.1. This number of compounds is lower than other reported studies, with a
comprehensive literature review reporting values for food volatiles compiling the data from six
cranberry studies reporting a total of 115 volatile compounds previously identified in cranberries
(De Vincenzi et al. 1989). In one of the studies reviewed that used American cranberry, 42
compounds were identified, which is closer to 25 compounds identified in this study (Croteau
and Fagerson 1968). The data from the previous studies should be compared to the current study
with discretion, taking into account that some of the papers reviewed used cranberry juice,
European cranberries, and cranberry press cake, which was denoted as the berry residue
remaining after the juice has been expressed, as the starting cranberry component for evaluation,
whereas the cranberries in this study are American cranberries grown and harvested in Oregon
(Anjou et al. 1967). Another thing possibly leading to these discrepancies with the literature is
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that the extracts obtained from the starting cranberry components were prepared for evaluation in
different manners, for example Croteau and Fagerson (1968) used a cold press technique and this
study used vacuum distillation.
The Folin- Ciocalteu assay was used to measure total phenolic content of the volatiles
and the values were zero, as expected. Table 4.2 show the results of the DPPH assay, measuring
for total antioxidant capacity, with total antioxidant capacity of the volatile extract calculated as
40.2 uM/kg +/- 0.72. Results for both of these assays were very low as expected. These assays
are typically not performed on volatile extracts, but they were in this study to keep consistency
between the data collected from the phenolic extract and the volatile extract. The results
demonstrate that the volatile fraction does not contain phenolics and the antioxidant activity of
the volatile fraction is very low when compared with the phenolic fraction.
Chapter 5: In Vitro Anti-Inflammatory Effect of Cranberry Phenolic and Volatile Extracts
on RAW 264.7 cells.
5.1 Introduction
To evaluate the anti-inflammatory capabilities of the cranberry phenolic and volatile
extracts, an in vitro nitric oxide (NO) assay was performed. Nitric oxide assays are used to
measure the total amount of nitrate/nitrite and are commonly used in experiments studying free
radical scavenging, anti-cancer properties, anti-ageing properties, and anti-inflammatory
properties (Kagoo and Chellathai 2014). In this case, NO levels were measured as an
inflammatory marker. A set number of cells were treated with LPS (to stimulate inflammation
and NO production), then treated with another substance and given time for that substance to
have its’ effect on the cells (level of NO produced). Then the NO levels produced by the treated
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cells compared to non-treated (control) were measured using colorimetric analysis to assess the
anti-inflammatory properties of the treatments.
One concern that had to be addressed in methodology of this study was the solubility of
the volatile compounds in the aqueous media. Because of the lipophilic nature of volatile
compounds, a surfactant was needed to ensure suspension of the volatile compounds in the
volatile treatment media. In all dilutions of the volatile treatments, there was a final
concentration of 0.02% tween 80, a non-ionic surfactant, to ensure that the volatiles dispersed
throughout the experimental media and were available to treat the cells. Tween 80 was chosen
because it has been previously shown to work in cell culture and to hold volatile compounds in
suspension in cell culture media (O’Sullivan et al. 2004). Tween 80 was found to be noncytotoxic to RAW 264.7 cells at the 0.02% concentration used in this study using the CellTiter
96® Aqueous One Solution Cell Proliferation (Inah Gu, MS Thesis).
RAW 264.7 cells, a mouse macrophage cell line from mouse blood, were chosen for the
NO assay because the macrophage is a major cell type involved in inflammation, and because of
the well-known anti-inflammatory properties of cranberries (Bodet et al. 2006).
5.2 Materials
Cranberry phenolic and volatile extracts, explained in chapters 3 and 4 respectively, were
used as the treatments in cell culture prior to the NO assay. The RAW 264.7 mouse macrophage
cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD) and
cultured in Dulbecco’s modified eagle's medium (DMEM) enriched with 1% penicillinstreptomycin, 1% L-glutamine, and 10% fetal bovine serum (FBS). The components for the
DMEM media and all cell culture experimental reagents were purchased from Gibco® through
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Life Technologies (Carlsbad, CA). The Griess Reagent System kit was purchased from Promega
Corporation (Madison, WI).
5.3 Treatment Dosage of Cranberry Phenolic and Volatile Extracts
Phenolic and volatile extracts (reference chapters 3 and 4) were used as experimental
treatments on RAW 264.7 cells before measuring the NO levels. The extracts were brought back
to the original starting weight of the fresh cranberries so that they accurately reflect the natural
concentrations of the phenolics and volatiles in a fresh cranberry. Due to the cells need for
nutrient-rich media, the extracts could not be applied directly to the cells because of potential cell
death. To keep the treatment dosage as high as possible, 2x, 4x, and 8x dilutions of the phenolic
and volatile extracts were used. The prescribed 2x, 4x, and 8x dilutions of phenolic and volatile
extracts were found to be non-toxic to the cells via the The CellTiter 96® AQueousOne Solution
Cell Proliferation Assay in a preliminary study (Inah Gu, MS Thesis).
Treatment of the RAW 264.7 cells in this manner, with the same dilutions of phenolic
and volatile extracts, rather than treatment with the same concentration of each extract, is
justified by the fact that the concentrations of these compounds are not equivalent in a fresh
cranberry. This study is representative of the amount of phenolics and volatiles that a person
would obtain by eating fresh cranberries. Actual concentrations of treatment extracts are listed in
Table 5.1.
Table 5.1 Concentrations of cranberry phenolic and volatile compounds applied as treatments to
RAW 264.7 Cells

1

Treatment

1

Volatile Fraction

3.6 ppm

Actual Concentration

2x dilution

4x dilution

8x dilution

1.80 ppm

0.90 ppm

0.45 ppm

Phenolic Fraction 1271.3 ppm
635.7 ppm
317.8 ppm
Actual concentration refers to starting concentration in total extracts.

158.9 ppm
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5.4 Methods
5.4.1 Cell Culture
RAW 264.7 mouse microphage cells were purchased from the American Type Culture
Collection (ATCC, Rockville, MD) and cultured in Dulbecco’s modified eagle's medium
(DMEM) enriched with 1% penicillin-streptomycin, 1% L-glutamine, and 10% fetal bovine
serum (FBS). The cells were maintained in 75 cm2 cell culture flasks and incubated at 37 °C in a
5% CO2 environment. All NO assays were conducted between cell passage numbers 4-8. The
components for the DMEM media and all experimental reagents were purchased from Gibco®
through Life Technologies (Carlsbad, CA).
5.4.2 Griess Reagent System Assay (NO Assay)
Nitric oxide production was analyzed using the Griess Reagent System kit containing
nitrite standard, N-1-napthylethylenediamine dihydrochloride (NED) solution, and sulfanilamide
solution, which was purchased from Promega Corporation (Madison, WI). 100 µL of RAW
264.7 cells in enriched DMEM media were seeded in a 96 well plate (plate 1) and incubated at
37 °C and 5% CO2 for 16 hr. After 16 hr, which allowed the cells to attach to bottom of the wells
in the plate, the media was removed and treatment media containing a range of phenolic and
volatile cranberry extracts was added, tween 80 was added at a concentration of 0.02% to the
volatile treatment media. The treatment media was left on the cells for 1 hr, and then removed.
Next, lipopolysaccharide (LPS) media, concentration 100 ng LPS per mL, was applied to the
cells and left on for 24 hr. After 24 hr, the LPS media was removed and the nitric oxide levels
were measured. To measure nitric oxide, a nitrite standard reference curve, with concentrations
ranging from 0 to 100 µM, was prepared on a separate 96 well plate (plate 2). Samples on plate 1
were centrifuged for 1 min at 1000 rpm and the supernatants from the samples were added to
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plate 2. Then, 50 µL of sulfanilamide solution was added to the standard reference curve and the
samples on plate 2 and allowed to sit for 10 min protected from light. After ten min, 50 µL of
NED solution was added to all wells on plate 2 and allowed to sit protected from light for 10
min. After 10 min, the absorbance was read on a plate reader at 540 nm. After the absorbance
readings, corrections were made to account for background absorbance of the sample control
media. The absorbance readings were converted into nitric oxide levels using the slope value
from the nitric oxide standard curve.
This experiment was conducted as described above, with the cranberry treatments applied
before the LPS, and the reverse, with the cranberry treatments applied after the LPS. For the
reverse, the RAW 264.7 cells were seeded in the 96 well plate and allowed to sit for 16 hr. After
16 hr the media was removed and the LPS media was applied. The LPS media was left on the
cells for 24 hr. After 24 hr the cranberry phenolic and volatile treatment media containing the
different concentrations was added, and a final concentration of 0.02% tween 80 was added to
the volatile treatment media. After 1 hr with the cranberry treatment media, the plate was
centrifuged, the supernatant transferred to a second plate, and the nitric oxide levels measured in
the same way as described when treatments were applied before LPS.
5.5 Statistical Analysis
All statistical analysis was performed using JMPâ Pro Ver. 14 Statistics Software. Oneway analysis of variance for all responses for all treatment dilution combinations before and after
by each treatment combination was ran in the Fit Y by X platform of JMP Pro Ver. 14. Multiple
comparisons were performed using the Tukey HSD test.
Paired t-tests were used in the Matched Pair platform of JMP Pro Ver. 14 to compare the
before and after LPS results for each treatment.
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5.6 Results
5.6.1 Phenolic and Volatile Extract Treatments after Applying LPS

NO Production

-5.000

Vol 450 ppb

0.000

b
*
Vol 900 ppb

5.000

c
*

ab

*Vol 1.8 ppm

10.000

CTR w/ LPS

15.000

*Phe 635.7 ppm

bc
*

*Phe 317.8 ppm

20.000

b
*

ab

ab

Phe 158.9 ppm

a

25.000

CTR

Avg NO Concentration (uM)

30.000

Treatments (n=15)

Figure 5.1 Average NO concentration produced by RAW 264.7 cells treated with phenolic and
volatile compounds after applying LPS. * indicates a significant difference from the positive
control (CTR w/ LPS). Levels not connected by the same letter are significantly different.
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Table 5.2 Means comparisons of all pairs treatment after LPS using Tukey-Kramer HSD
Confidence Quantile.
Control- Volatile- Phenolic Volatile- Phenolic Volatile- Phenolic Control0x+
8x
-8x
4x
-4x
2x
-2x
0xControl0x+

-6.6141

-3.3605

-3.2148

-1.7156

0.0595

0.7510

2.3771

8.3440

Volatile450 ppb

-3.3605

-6.6141

-6.4684

-4.9692

-3.1941

-2.5026

-0.8765

5.0904

Phenolic158.9
ppm

-3.2148

-6.4684

-6.6141

-5.1150

-3.3398

-2.6483

-1.0222

4.9446

Volatile900 ppb

-1.7156

-4.9692

-5.1150

-6.6141

-4.8390

-4.1474

-2.5214

3.4455

Phenolic317.8
ppm

0.0595

-3.1941

-3.3398

-4.8390

-6.6141

-5.9226

-4.2965

1.6704

Volatile900 ppb

0.7510

-2.5026

-2.6483

-4.1474

-5.9226

-6.6141

-4.9880

0.9788

Phenolic635.7
ppm

2.3771

-0.8765

-1.0222

-2.5214

-4.2965

-4.9880

-6.6141

-0.6472

Control0x-

8.3440

5.0904

4.9446

3.4455

1.6704

0.9788

-0.6472

-6.6141

Positive values show pairs of means that are statistically significant.
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5.6.2 Phenolic and Volatile Extract Treatments before Applying LPS

NO Production
a

2.000
0.000
-2.000

e
*

Vol 1.8 ppm

4.000

d
*
Phe 158.9 ppm

6.000

CTR w/ LPS

8.000

Phe 635.7 ppm

d
*

10.000

c
*
Phe 317.8 ppm

12.000

bc
*

ab

Vol 450 ppb

ab

14.000

Vol 900 ppb

16.000

CTR

Avg NO Concentration (uM)

18.000

Treatments (n=15)

Figure 5.2 Average NO concentration produced by RAW 264.7 cells treated with phenolic and
volatile extracts before applying LPS. * indicates a significant difference from the positive
control (CTR w/ LPS). Levels not connected by the same letter are significantly different.
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Table 5.3 Means comparisons of all pairs treatment before LPS using Tukey-Kramer HSD
Confidence Quantile
Control- Volatile- Phenolic Volatile- Phenolic Volatile- Phenolic Control0x+
8x
-8x
4x
-4x
2x
-2x
0x-

Control0x+

-2.934

-2.534

-0.459

0.064

2.978

7.858

9.101

19.235

Volatile450 ppb

-2.534

-2.934

-0.859

-0.336

2.579

7.458

8.701

18.835

Phenolic158.9
ppm

-0.459

-0.859

-2.934

-2.411

0.503

5.383

6.626

16.760

Volatile900 ppb

0.064

-0.336

-2.411

-2.934

-0.019

4.860

6.103

16.237

Phenolic317.8
ppm

2.978

2.579

0.503

-0.019

-2.934

1.946

3.188

13.322

Volatile1.8 ppm

7.858

7.458

5.383

4.860

1.946

-2.934

-1.691

8.443

Phenolic635.7
ppm

9.101

8.701

6.626

6.103

3.188

-1.691

-2.934

7.200

Control0x-

19.235

18.835

16.760

16.237

13.322

8.443

7.200

-2.934

Positive values show pairs of means that are statistically significant.
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5.6.3 Analysis of Treating After vs. Treating Before Applying LPS

Control-0xControl-0x+
Figure 5.3 Comparison of NO levels of controls in experiments before and after LPS. NO
Conc_A = treatment after LPS, NO Conc_B = treatment before LPS.
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Phenolic 635.7 ppm

Phenolic 317.8 ppm

Phenolic 158.9 ppm

Volatile 1.8 ppm

Volatile 900 ppb
Volatile 450 ppb
Figure 5.4 Comparison of NO levels treating with phenolic and volatile extracts before and after
LPS. Conc_A = treatment after LPS, NO Conc_B = treatment before LPS.
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5.7 Discussion
Upon statistical analysis of the data, the results of this study supported the proposed
hypothesis that the volatile compounds contributed along with the phenolic compounds in the
anti-inflammatory effect of cranberries. First, the results of application of the treatments after
applying LPS will be discussed. Figure 5.1 along with the data listed in Table 5.2 show that
application of cranberry phenolic and volatile extract treatments after applying LPS decreased
NO levels compared to the positive control. The phenolic 635.7 ppm and 317.8 ppm treatments
and the volatile 1.8 ppm treatment significantly lowered the amount of NO produced compared
to the positive control. A relevant dose response is also shown in the results. That is as the
dilution factor of the treatment extracts increased, the significance of the NO levels compared to
the positive control decreased, showing that the more concentrated treatment extracts worked
better to eliminate the pre-existing NO induced by LPS. Interestingly, the results of the phenolic
635.7 ppm and volatile 1.8 ppm treatment extracts were not significantly different from one
another, but were both significantly different from the positive control, indicating they had the
same treatment effect on lowering pre-existing NO. This is important to note because although
both extracts were prepared at a 2x dilution of the starting concentration in a cranberry, the 2x
dilution of the volatile extract was 353x less than the concentration of the 2x dilution of the
phenolic extract. So even at this extremely low concentration the volatile extract at 1.8 ppm
worked just as well as the phenolic extract at 635.7 ppm at treating pre-existing NO. Also, the
phenolic extract treatment at 635.7 ppm shared a letter with the negative control, the cells
without any exposure to LPS, indicating that the NO levels of the phenolic 635.7 ppm extract
treatment showed no significant difference from the cells that had no inflammation induced. Pvalues of all treatments compared to the positive control are listed in the appendix, with the
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significant values as follows: phenolic 635.7 ppm with a p-value of 0.0014, phenolic 317.8 ppm
with a p-value of 0.0463, and volatile 1.8 ppm with a p-value of 0.0180.
The results of the treatment of the cells before applying LPS also supported the
hypothesis that the volatile compounds contribute along with the phenolic compounds in the
anti-inflammatory effect of cranberries. Figure 5.2 along with the data in Table 5.3 shows that
application of cranberry phenolic and volatile extract treatments before applying LPS decreased
NO levels compared to the positive control, demonstrating a preventative effect. Both phenolic
and volatile extract treatments at 2x (635.7 ppm and 1.8 ppm respectively) and 4x dilutions
(317.8 ppm and 900 ppb respectively) significantly lowered the amount of NO produced
compared to the positive control. A relevant dose response is also shown in the results when the
experiment was conducted in this manner. As the dilution factor of the treatment extracts
increased, the significance of the NO levels compared to the positive control was reduced,
showing that the more concentrated treatment extracts worked better to prevent the cells from
producing NO when inflammation was induced by LPS after treatment. Interestingly, the results
of the 2x and 4x dilutions of the phenolic and volatile extracts were not significantly different
from one another but were all significantly different from the positive control. This indicates that
when used as a preventative method, the phenolic and volatile treatments at the 2x dilution
(635.7 ppm and 1.8 ppm respectively) had the same treatment effect and the phenolic and
volatile treatments at the 4x dilution (317.8 ppm and 900 ppb respectively) had the same
treatment effect, as opposed to only having the same treatment effect at the 2x dilution when
applied as a treatment after the application of LPS. It is important to note again that the volatile
extract dilution concentrations were 353x lower than the respective phenolic extract dilution
concentrations and worked just as well to prevent the production of NO. P-values of all
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treatments compared to the positive control are listed in Appendix B, with the significant values
as follows: phenolic 635.7 ppm with a p-value of <.0001, phenolic 317.8 ppm with a p-value of
<.0001, volatile 1.8 ppm with a p-value of <.0001, and volatile 900 ppb with a p-value of 0.0415.
Upon statistical comparison of the two treatment strategies, applying the treatments
before inducing inflammation with LPS versus applying the treatments after inducing
inflammation with LPS, it was clear that applying the treatments before inducing inflammation
with LPS resulted in lower NO levels in all cases (Figure 5.3 and Figure 5.4). This indicates that
the phenolic and volatile extract treatments worked better as a preventative treatment for
inflammation rather than a treatment for pre-existing inflammation.
The results of the anti-inflammatory effect of the phenolic extract agreed with other
studies where the total cranberry phenolic fraction or a specific portion of the total phenolic
fraction tested on other cell lines, all exhibited an anti-inflammatory effect (La et al. 2010, Bodet
et al. 2006, Feghali et al. 2012). There has been little to no research conducted on volatile
compounds and their anti-inflammatory capabilities in vitro, so there is not any direct literature
to compare the anti-inflammatory effect of the volatile extract.
The mechanisms of how the phenolic and volatile treatments work to prevent and treat
inflammation are unclear. From the Griess Reagent System assay used in this study, only the
levels of NO produced were measured, i.e. the amount of a specific inflammatory marker that is
present. One possible reason for why cranberry phenolic compounds exhibit anti-inflammatory
effects is their ability to inhibit cells from producing pro-inflammatory cytokines including
interleukin-8 (IL-8) and chemokine ligand 5 (CCL5) and to reduce the activation of the nuclear
factor-kB (NF-kB) p65 pathway when inflammation is induced by LPS (Bodet et al. 2006).
Another study attributed the anti-inflammatory capabilities of cranberry extract to its’ high
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antioxidant capacity, showing the extract inhibited kB kinase b, which is a central node in
inflammatory signal transduction (Heim et al. 2012). Similar mechanisms to those reported in the
literature could have occurred in this study following treatment with the cranberry phenolic
extract, however the studies used different cell lines and possibly used different types of
cranberries. The volatile compounds could be reducing the aforementioned pathways and
cytokines in the same way, but further research is necessary to uncover that information.
Interestingly, the antioxidant activity of the volatile extract 40 µM/Kg was much lower than that
of the phenolic fraction, 4676 µM/Kg, indicating that suppression of oxidative stress may not
play an important role in prevention of inflammation by the volatile fraction.
The NO assay has limitations, which are important to consider. Number one, the doses of
the cranberry phenolic and volatile extracts that were used to treat the RAW 264.7 cells were
lower than the actual concentration in a cranberry. However, the dilutions were necessary due to
needs of the RAW 264.7 cells for media and nutrients. Even at these dilutions, some of the
phenolic and volatile extract treatments showed a significant anti-inflammatory effect on the
RAW 264.7 cells compared to the positive control, when treated both before and after applying
LPS, especially at the 2x dilution (635.7 ppm phenolic and 1.8 ppm volatile) of both extracts.
Taking into consideration that cranberries can be consumed fresh or without the dilutions
required for this study, it is reasonable to hypothesize an even stronger anti-inflammatory effect
could be observed in an in vivo study.
A second limitation of this study was the quantification of only one inflammatory marker.
Other biological markers of inflammation include interleukin-6, TNF-a, and C-reactive protein
(Kalogeropoulos et al. 2010) It would have been beneficial to have measured the interleukin-6
levels using an IL-6 Enzyme Linked ImmunoSorbent Assay Kit, TNF-a levels using a TNF-a
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Enzyme Linked ImmunoSorbent Assay Kit, and C-reactive protein levels using a CRP
Quantikine Enzyme Linked ImmunoSorbent Assay kit, however, these assays were not
performed due to time constraints.
Another area of limitation in this study was that the RAW 264.7 cell line used was a
mouse macrophage cell line, not a human cell line, so possible differences could be observed in a
human cell line. Also, this study was conducted in vitro, and the in vivo effects could be different
if a similar study was conducted on live mice or humans. The current literature is deficient in the
overall bioavailability of volatile compounds, and their ability to reach macrophage cells after
ingestion from a food source, such as cranberries. A future study involving a lung cell line could
be beneficial because volatile compounds have been previously reported to be absorbed and
retained at close to the original dose in the lungs during inhalation (Kohlert et al. 2000).
Although this anti-inflammatory study had limitations, there were also strengths. Using
multiple different concentrations of the phenolic and volatile extract treatments to see if the dose
was relevant was beneficial to see the minimum amount of treatment required to get a significant
change in the NO level. Another strength of this study included starting with the respective
concentrations of phenolic and volatile compounds present in a fresh cranberry, even though they
were not the same, to mimic the effects of the amount of phenolic and volatile compounds
available from consuming a fresh cranberry. Testing the phenolic and volatile extracts at
equivalent concentrations may have yielded lower levels of NO with the volatile extract, but due
to the 353x lower concentration of volatile compounds compared to the concentration of
phenolic compounds in cranberries, testing them in the manner used in this study mimics the
amounts of the compounds that would be potentially available in vivo after consuming a
cranberry.
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Chapter 6: Anti-Inflammatory Effect of a-terpineol, Linalool, Linalool oxide, and
Eucalyptol on RAW 264.7 cells in vitro.
6.1 Introduction
A secondary objective of this study was to explore the anti-inflammatory capabilities of
four of the most abundant individual volatile compounds found in cranberry volatile extract, aterpineol, linalool, linalool oxide, and eucalyptol, in vitro using the Griess Reagent System NO
assay. The purpose of exploring each of these individual volatile compounds for their antiinflammatory capabilities, rather than the anti-inflammatory capabilities of the entire extract, was
to see if certain individual volatile compounds play a larger role in reducing inflammation than
others. Treatment dosages for this objective were determined in the same manner as all other
treatment dosages in this study, starting from each of the individual concentrations in the total
volatile extract, 2x, 4x, and 8x dilutions were prepared. Actual concentrations of each applied
treatment are shown in Table 6.1.
Table 6.1 Concentrations of individual volatile compounds applied as treatments to RAW 264.7
Cells
1
Actual
Treatment
Concentration
2x dilution 4x dilution 8x dilution
Alpha-terpineol 2320.6 ppb
1160.3 ppb 580.2 ppb
290.1 ppb
Linalool oxide
224.4 ppb
112.2 ppb
56.1 ppb
28.1 ppb
Eucalyptol
189.0 ppb
94.5 ppb
47.3 ppb
23.7 ppb
Linalool
41.3 ppb
20.7 ppb
10.3 ppb
5.2 ppb
1
Actual concentration refers to starting concentration in total volatile extract
6.2 Materials
All standard compounds a-terpineol, linalool, linalool oxide, and eucalyptol were
purchased from Sigma Aldrich (St. Louis, MO). The Griess Reagent System NO assay kit was
purchased from Promega Corporation (Madison, WI).

46

6.3 Methods
6.3.1 Cell Culture
RAW 264.7 mouse macrophage cells were purchased from the American Type Culture
Collection (ATCC, Rockville, MD) and cultured in Dulbecco’s modified eagle's medium
(DMEM) enriched with 1% penicillin-streptomycin, 1% L-glutamine, and 10% fetal bovine
serum (FBS). The cells were maintained in 75 cm2 cell culture flasks and incubated at 37 °C in a
5% CO2 environment. All NO assays were conducted between cell passage numbers 4-8. The
components for the DMEM media and all experimental reagents were purchased from Gibco®
through Life Technologies (Carlsbad, CA).
6.3.2 Griess Reagent System Assay (NO Assay)
Nitric oxide production was analyzed using the Griess Reagent System kit containing
nitrite standard, N-1-napthylethylenediamine dihydrochloride (NED) solution, and sulfanilamide
solution, which was purchased from Promega Corporation (Madison, WI). 100 µL of RAW
264.7 cells in enriched DMEM media were seeded in a 96 well plate (plate 1) and incubated at
37 °C and 5% CO2 for 16 hr. After 16 hr, which allowed the cells to attach to bottom of the wells
in the plate, the media was removed and test media containing different concentrations of aterpineol, linalool, linalool oxide, and eucalyptol was added. The treatment media was left on the
cells for 1 hr, and then removed. Next, lipopolysaccharide (LPS) media, concentration 100 ng
LPS per mL, was applied to the cells and left on for 24 hr. After 24 hr, the LPS media was
removed and the nitric oxide levels were measured. To measure the nitric oxide, a nitrite
standard reference curve, with concentrations ranging from 0 to 100 µM, was prepared on a
separate 96 well plate (plate 2). Samples on plate 1 were centrifuged for 1 min at 1000 rpm and
the supernatants from the samples were added to plate 2. Then, 50 µL of sulfanilamide solution
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was added to the standard reference curve and the samples on plate 2 and allowed to sit for 10
min protected from light. After ten minutes, 50 µL of NED solution was added to all wells on
plate 2 and allowed to sit protected from light for 10 min. After 10 min, the absorbance was read
on a plate reader at 540 nm. After the absorbance readings, corrections were made to account for
background absorbance of the sample control media. The absorbance readings were converted
into nitric oxide levels using the slope value from the nitric oxide standard curve.
This experiment was conducted as described above, with the a-terpineol, linalool,
linalool oxide, and eucalyptol treatments applied before the LPS, and the reverse, with the
treatments applied after the LPS. For the reverse, the RAW 264.7 cells were seeded in the 96
well plate and allowed to sit for 16 hr. After 16 hr the media was removed and the LPS media
was applied. The LPS media was left on the cells for 24 hr. After 24 hr the a-terpineol, linalool,
linalool oxide, and eucalyptol treatment medias at different concentrations were added. After 1
hr with the treatment media, the plate was centrifuged, the supernatant transferred to a second
plate, and the nitric oxide levels measured in the same way as described when treatments were
applied before LPS.
6.4 Statistical Analysis
All statistical analysis was performed using JMPâ Pro Ver. 14 Statistics Software. Oneway analysis of variance for all responses for all treatment dilution combinations before and after
by each treatment combination was ran in the Fit Y by X platform of JMP Pro Ver. 14. Multiple
comparisons were performed using the Tukey HSD test.
Paired t-tests were used in the Matched Pair platform of JMP Pro Ver. 14 to compare the
before and after LPS results for each treatment.
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6.5 Results
6.5.1 Standard Treatments after Applying LPS

NO Production
a

a

a

a

a

a

Linalool 21 ppb

Eucalyptol 24 ppb

Eucalyptol 47 ppb

Eucalyptol 95 ppb
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Linalool-Oxide 56 ppb

Linalool-Oxide 112 ppb

Alpha-t 290 ppb
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Alpha-t 1160 ppb

c
*
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10.000
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Avg NO Concentration (uM)

15.000

-5.000
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b
*

20.000

0.000

a
a

a
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5.000
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Linalool 5 ppb

a

30.000

Linalool 10 ppb

35.000
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Figure 6.1 Average NO concentration produced by RAW 264.7 cells treated with a-terpineol,
linalool, linalool oxide, and eucalyptol standards after applying LPS. * indicates a statistically
significant difference from the positive control (CTR w/ LPS). Levels not connected by the same
letter are significantly different.
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Table 6.2.1 Means Comparisons of all pairs standard treatments after LPS using Tukey-Kramer
HSD Confidence Quantile
AlphaLinalool Linalool
Eucalyptol Control
Linalool Linalool
Terpineol
-oxide-oxide-8x
-0x+
-8x
-4x
-8x
8x
4x
Eucalyptol
-6.658
-6.265
-6.257
-6.204
-6.156
-6.085
-6.022
-8x
Control-6.265
-6.658
-6.649
-6.597
-6.548
-6.478
-6.414
0x+
AlphaTerpineol-6.257
-6.649
-6.658
-6.606
-6.557
-6.487
-6.423
8x
Linalool-6.204
-6.597
-6.606
-6.658
-6.61
-6.539
-6.476
8x
Linalool-6.156
-6.548
-6.557
-6.61
-6.658
-6.588
-6.524
4x
Linalool-6.085
-6.478
-6.487
-6.539
-6.588
-6.658
-6.594
oxide-8x
Linalool-6.022
-6.414
-6.423
-6.476
-6.524
-6.594
-6.658
oxide-4x
Eucalyptol
-5.853
-6.246
-6.255
-6.307
-6.356
-6.426
-6.49
-4x
Linalool-2.878
-3.271
-3.279
-3.332
-3.38
-3.451
-3.514
oxide-2x
Linalool-2.608
-3.001
-3.009
-3.062
-3.11
-3.181
-3.244
2x
AlphaTerpineol-2.318
-2.711
-2.72
-2.772
-2.821
-2.891
-2.955
4x
Eucalyptol
-1.518
-1.91
-1.919
-1.972
-2.02
-2.09
-2.154
-2x
AlphaTerpineol5.592
5.199
5.19
5.138
5.089
5.019
4.955
2x
Control20.552
20.159
20.151
20.098
20.05
19.979
19.916
0xPositive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x,
and 8x shown after standard name have the following concentrations respectively, alphaterpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb,
eucalyptol 94.5 ppb, 47.3 ppb, 23.7 ppb, linalool 20.7 ppb, 10.3 ppb, 5.2 ppb.
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Table 6.2.2 Means Comparisons of all pairs standard treatments after LPS using Tukey-Kramer
HSD Confidence Quantile
Linaloo
AlphaAlphaEucalypto
Linaloo
Eucalypto
Contro
l-oxideTerpineo
Terpineo
l-4x
l-2x
l-2x
l-0x2x
l-4x
l-2x
Eucalypto
-5.853
-2.878
-2.608
-2.318
-1.518
5.592 20.552
l-8x
Control-6.246
-3.271
-3.001
-2.711
-1.91
5.199 20.159
0x+
AlphaTerpineol
-6.255
-3.279
-3.009
-2.72
-1.919
5.19 20.151
-8x
Linalool-6.307
-3.332
-3.062
-2.772
-1.972
5.138 20.098
8x
Linalool-6.356
-3.38
-3.11
-2.821
-2.02
5.089
20.05
4x
Linalool-6.426
-3.451
-3.181
-2.891
-2.09
5.019 19.979
oxide-8x
Linalool-6.49
-3.514
-3.244
-2.955
-2.154
4.955 19.916
oxide-4x
Eucalypto
-6.658
-3.682
-3.413
-3.123
-2.322
4.787 19.747
l-4x
Linalool-3.682
-6.658
-6.388
-6.099
-5.298
1.811 16.772
oxide-2x
Linalool-3.413
-6.388
-6.658
-6.369
-5.568
1.542 16.502
2x
AlphaTerpineol
-3.123
-6.099
-6.369
-6.658
-5.857
1.252 16.212
-4x
Eucalypto
-2.322
-5.298
-5.568
-5.857
-6.658
0.451 15.412
l-2x
AlphaTerpineol
4.787
1.811
1.542
1.252
0.451
-6.658
8.302
-2x
Control19.747
16.772
16.502
16.212
15.412
8.302
-6.658
0xPositive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x,
and 8x shown after standard name have the following concentrations respectively, alphaterpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb,
eucalyptol 94.5 ppb, 47.3 ppb, 23.7 ppb, linalool 20.7 ppb, 10.3 ppb, 5.2 ppb.
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6.5.2 Standard Treatments before Applying LPS

-2.000

a

Linalool 5 ppb

0.000

Alpha-t 290 ppb

2.000

f
*

Alpha-t 580 ppb

4.000

CTR w/ LPS
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Alpha-t 1160 ppb

8.000
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bcd
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de
*

Linalool 21 ppb

10.000

a

Eucalyptol 24 ppb

e
*

cd
*

de
*

a

Eucalyptol 47 ppb

12.000
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Avg NO Concentration (uM)

14.000

a

Linalool-Oxide 28 ppb

16.000

abc

Eucalyptol 95 ppb

abc

Linalool-Oxide 56 ppb

a

Linalool-Oxide 112 ppb

18.000

Linalool 10 ppb

NO Production

Treatments (n=15)

Figure 6.2 Average NO concentration produced by RAW 264.7 cells treated with a-terpineol,
linalool, linalool oxide, and eucalyptol standard treatments before applying LPS. * indicates a
statistically significant difference from the positive control (CTR w/ LPS). Levels not connected
by the same letter are significantly different.
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Table 6.3.1 Means Comparisons of all pairs of standard treatments before LPS using TukeyKramer HSD Confidence Quantile
Linalool
Linalool
Control Linalool Eucalyptol Eucalyptol Linalool
-oxide-oxide-0x+
-8x
-4x
-8x
-4x
8x
4x
Linalooloxide-8x
Control0x+
Linalool8x
Eucalyptol
-4x
Eucalyptol
-8x
Linalool4x
Linalooloxide-4x
AlphaTerpineol8x
Linalool2x
Linalooloxide-2x

-3.054

-2.924

-2.885

-2.848

-2.759

-2.697

-2.494

-2.924

-3.054

-3.015

-2.978

-2.889

-2.827

-2.624

-2.885

-3.015

-3.054

-3.018

-2.929

-2.867

-2.664

-2.848

-2.978

-3.018

-3.054

-2.965

-2.903

-2.7

-2.759

-2.889

-2.929

-2.965

-3.054

-2.992

-2.789

-2.697

-2.827

-2.867

-2.903

-2.992

-3.054

-2.851

-2.494

-2.624

-2.664

-2.7

-2.789

-2.851

-3.054

-2.433

-2.563

-2.603

-2.639

-2.728

-2.79

-2.993

0.347

0.217

0.177

0.141

0.051

-0.011

-0.213

0.413

0.283

0.243

0.207

0.118

0.056

-0.147

Eucalyptol
0.964
0.834
0.794
0.758
0.668
0.606
0.404
-2x
AlphaTerpineol1.342
1.213
1.173
1.137
1.047
0.985
0.783
4x
AlphaTerpineol3.667
3.538
3.498
3.462
3.372
3.31
3.108
2x
Control12.573
12.443
12.403
12.367
12.278
12.216
12.013
0xPositive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x,
and 8x shown after standard name have the following concentrations respectively, alphaterpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb,
eucalyptol 94.5 ppb, 47.3 ppb, 23.7 ppb, linalool 20.7 ppb, 10.3 ppb, 5.2 ppb.
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Table 6.3.2 Means Comparisons of all pairs of standard treatments before LPS using TukeyKramer HSD Confidence Quantile.
AlphaLinaloo
AlphaAlphaLinaloo
Eucalypto
Control
Terpineo
l-oxideTerpineo Terpineo
l-2x
l-2x
-0xl-8x
2x
l-4x
l-2x
Linalool-2.433
0.347
0.413
0.964
1.342
3.667 12.573
oxide-8x
Control-2.563
0.217
0.283
0.834
1.213
3.538 12.443
0x+
Linalool-2.603
0.177
0.243
0.794
1.173
3.498 12.403
8x
Eucalypto
-2.639
0.141
0.207
0.758
1.137
3.462 12.367
l-4x
Eucalypto
-2.728
0.051
0.118
0.668
1.047
3.372 12.278
l-8x
Linalool-2.79
-0.011
0.056
0.606
0.985
3.31 12.216
4x
Linalool-2.993
-0.213
-0.147
0.404
0.783
3.108 12.013
oxide-4x
AlphaTerpineol-3.054
-0.275
-0.208
0.342
0.721
3.046 11.952
8x
Linalool-0.275
-3.054
-2.988
-2.437
-2.058
0.267
9.172
2x
Linalool-0.208
-2.988
-3.054
-2.503
-2.125
0.2
9.106
oxide-2x
Eucalypto
0.342
-2.437
-2.503
-3.054
-2.675
-0.35
8.555
l-2x
AlphaTerpineol0.721
-2.058
-2.125
-2.675
-3.054
-0.729
8.176
4x
AlphaTerpineol3.046
0.267
0.2
-0.35
-0.729
-3.054
5.851
2x
Control11.952
9.172
9.106
8.555
8.176
5.851
-3.054
0xPositive values show pairs of means that are statistically significant. Dilution factors of 2x, 4x,
and 8x shown after standard name have the following concentrations respectively, alphaterpineol 1160.3 ppb, 580.2 ppb, 290.1 ppb, linalool-oxide 112.2 ppb, 56.1 ppb, 28.1 ppb,
eucalyptol 94.5 ppb, 47.3 ppb, 23.7 ppb, linalool 20.7 ppb, 10.3 ppb, 5.2 ppb.
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6.5.3 Analysis of Treating Before vs. Treating After Applying LPS

Control-0x-

Control-0x+

Figure 6.3 Comparison of NO levels of controls in experiments before and after LPS. Conc_A =
treatment after LPS, NO Conc_B = treatment before LPS.

Alpha-Terpineol 1160.3 ppb
Alpha-Terpineol 580.2 ppb
Alpha-Terpineol 290.1 ppb
Figure 6.4 Comparison of NO levels treating with alpha-terpineol before and after LPS.
NO_Conc_A = treatment after LPS, NO Conc_B = treatment before LPS.
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Eucalyptol 94.5 ppb

Eucalyptol 47.3 ppb

Eucalyptol 23.7 ppb

Figure 6.5 Comparison of NO levels treating with eucalyptol before and after LPS. NO_Conc_A
= treatment after LPS, NO Conc_B = treatment before LPS.

Linalool 20.7 ppb

Linalool 10.3 ppb

Linalool 5.2 ppb

Figure 6.6 Comparison of NO levels treating with linalool before and after LPS. NO_Conc_A =
treatment after LPS, NO Conc_B = treatment before LPS.

Linalool-oxide 112.2 ppb
Linalool-oxide 56.1 ppb
Linalool-oxide 28.1 ppb
Figure 6.7 Comparison of NO levels treating with linalool-oxide before and after LPS.
NO_Conc_A = treatment after LPS, NO Conc_B = treatment before LPS.
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6.6 Discussion
Results from the individual volatile standard treatment NO assays show potential for aterpineol, linalool, linalool oxide, and eucalyptol to act individually as anti-inflammatory agents,
especially a-terpineol. The hypothesis of this secondary objective was that each of the individual
volatile standards would have an anti-inflammatory effect compared to the positive control. The
results of the volatile standard treatment NO assays will be discussed in two parts, first with the
volatile standard treatments applied after inflammation was induced by LPS. Figure 6.1 along
with the data listed in Table 6.2.1 and Table 6.2.2 show that with application of the volatile
standard treatments after applying LPS compared to the positive control, a-terpineol at 1160.3
ppb was the only treatment that exhibited a statistically significant lower amount of NO with a pvalue of <.0001, p-values of all treatments compared to the positive control are listed in
Appendix B. These results are likely due to the dilutions of a-terpineol from the starting
concentration being the highest of all the standard compounds because it was found to have the
highest individual concentration in the cranberry total volatile extract.
Second, the results of the volatile standard treatments of the cells before applying LPS
supported the hypothesis that each of the individual volatile compounds would have an antiinflammatory effect compared to the positive control. Figure 6.2 and with the data listed in Table
6.3.1 and Table 6.3.2 show that with application of volatile standard treatments before applying
LPS compared to the positive control, i.e. looking at a preventative effect, NO levels decreased
after treatment by a-terpineol at 1160.3 ppb, a-terpineol at 580.2 ppb, linalool at 20.7 ppb,
linalool-oxide at 112.2 ppb, and eucalyptol at 94.5 ppb. A relevant dose response is also shown
in the results when the experiment was conducted in this manner. As the dilution factor of the
volatile standard treatments increased, the significance of the NO levels compared to the positive
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control was reduced, showing that the more concentrated treatments were more effective in
preventing the cells from producing as much NO when inflammation was induced by LPS after
treatment. The a-terpineol 1160.3 ppb exhibited significantly lower NO levels that all of the
other treatments that were statistically significant from the positive control, and the a-terpineol
580.2 ppb was not significantly different from linalool at 20.7 ppb, linalool-oxide at 112.2 ppb,
or eucalyptol at 94.5 ppb, indicating that all of those concentrations of volatile standard
treatments had the same preventative anti-inflammatory capabilities. P-values of all treatments
compared to the positive control are listed in Appendix B, with the significant values as follows:
a-terpineol 1160.3 ppb with a p-value of <.0001, a-terpineol 580.2 ppb with a p-value of 0.0003,
eucalyptol 94.5 ppb with a p-value of 0.0019, linalool-oxide 112.2 ppb with a p-value of 0.0184,
and linalool 20.7 ppb with a p-value of 0.0235.
Upon statistical comparison of the two treatment strategies, applying the treatments
before inducing inflammation with LPS versus applying the treatments after inducing
inflammation with LPS, applying the treatments before inducing inflammation with LPS resulted
in lower NO levels in all cases (Figures 6.3 - 6.7). This indicated that the volatile standard
treatments worked better as a preventative treatment for inflammation rather than a treatment for
pre-existing inflammation.
The standard a-terpineol exhibited the most effective anti-inflammatory effects on the
RAW 264.7 cells in this anti-inflammatory assay, being the only individual standard to work as
treatment to pre-existing NO and as a treatment to prevent NO production and lowering NO
levels compared to the control by 43.0% when applied after LPS and 43.3% when applied before
LPS. There is no other current data reporting the anti-inflammatory effects of a-terpineol on
RAW 264.7 cells for comparison, however a-terpineol has been shown to have anti58

inflammatory effects on other cell lines. In a study looking at epithelial buccal cells, a-terpineol
from orange juice was found to have an anti-inflammatory effect by reducing IL-6 production by
inhibiting the gene expression of the IL-6 receptor (Held et al. 2007). In another study on U937
human macrophage cells looking at tea tree oil steam distilled from Melaleuca alternifolia that
contains a-terpineol, the inflammation markers IL-b1, IL-6, and IL-10 induced by LPS were
found to be significantly reduced by treatment of the cells with the tea tree oil, and the
mechanism for the inhibition of the inflammatory markers was that the tea tree oil extract
components, specifically noted as a-terpineol and terpinen-4-ol, interfered with the NF-kB, p38,
extracellular signal-regulated kinase (ERK), or mitogen-activated protein kinase (MAPK)
pathways (Nogueira et al. 2014). In the present study, it is possible that these same pathways
were inhibited upon treatment with a-terpineol, but the differences in cell lines and source of the
a-terpineol must be considered upon comparison.
The standard eucalyptol exhibited an anti-inflammatory effect in the present study only
when applied to the RAW 264.7 cells as a treatment before inducing inflammation with LPS,
lowering NO levels by 25.4% compared to the positive control. There is no other current data
reporting the anti-inflammatory effects of eucalyptol on RAW 264.7 cells for comparison,
however eucalyptol has been shown to have anti-inflammatory effects. In an in vivo study on
mice, eucalyptol was found to inhibit the production of TNF-a, IL-b1, and IL-6 induced by
injection of complete Freund’s adjuvants, CFA, by a mechanism dealing with the transient
receptor potential cation channel subfamily M member 8, TRPM8, (Caceres et al. 2017). In
another study by Caceres Bustos et al. (2016), working on lung cells of mice, LPS was used to
induce inflammation, and after 24 hr, the lungs and bronchoalveolar lavage of eucalyptol treated
and untreated TRPM8 knockout and TRPM8 wild-type were taken to be analyzed and found that
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only the TRPM8 wild-type mice exhibited anti-inflammatory effects, showing that TRPM8 was
essential for eucalyptol to exhibit its anti-inflammatory capabilities. In another study involving
eucalyptol and inflammation on a different cell type, but similar time frame and induction of
inflammation to the present study, mice were intraperitoneally injected with eucalyptol one hr
before being challenged with LPS and compared to controls. The eucalyptol injected mice had
lower levels of TNF-a, IL-6, NO, and NF-kB (Kim et al. 2015). These studies support the data
in the present study that eucalyptol works as a suppressor of anti-inflammatory markers when
used as a pre-treatment to induced inflammation, and also that the mechanism for the antiinflammatory properties of eucalyptol in this study could have involved TRPM8, however
comparisons between the studies must be done with caution due to the use of different cell lines.
Confirmation of the mechanisms and suppression of other anti-inflammatory markers besides
NO on RAW 264.7 cells warrants future research.
The standard linalool-oxide exhibited an anti-inflammatory effect in the present study
only when applied to the RAW 264.7 cells as a treatment before inducing inflammation with
LPS, lowering NO levels by 21.8% compared to the positive control. There is no other current
data reporting the anti-inflammatory effects of linalool-oxide for comparison, therefore the
mechanisms and the ability to suppress other anti-inflammatory markers in RAW 264.7 cells
warrants future research.
The standard linalool exhibited an anti-inflammatory effect in the present study only
when applied to the RAW 264.7 cells as a treatment before inducing inflammation with LPS,
lowering NO levels by 21.4% compared to the positive control. There is one other current study
reporting the anti-inflammatory effects of linalool on RAW 264.7 cells for comparison. Huo et
al. (2013) investigated the preventative effect of linalool in vitro on RAW 264.7 cells and in vivo
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on a lung injury model and found that linalool lowered the production of TNF-a, and IL-6 in
vitro and in vivo compared to controls. This study looked at different biological markers of
inflammation than the present study but confirms the preventative effect of linalool on RAW
264.7 cells as a treatment for inflammation. There are other studies that have looked at linalool
and the anti-inflammatory effect. In a study evaluating the anti-inflammatory effects of linalool
from Cinnamomum osmophloeum Kanehira, a Taiwan native plant, mice were administered
linalool at 2.6 and 5.2 mg per kg of body weight before injected with endotoxin to induce
inflammation, and the mice treated with linalool were found to have decreased levels of the
inflammatory markers peripheral nitrate and nitrite, IL-1b, IL-18, TNF-a, and IFN-l (Lee et al.
2018) Contrary to the anti-inflammatory effect found in the present study and other current
studies, in the study by Held et al. (2007) linalool identified in orange juice was found to have no
effect on the production of the pro-inflammatory cytokine IL-6, and was found to have no
inhibition of gene expression of the IL-6 receptor in epithelial buccal cells and overall no antiinflammatory effect. However, the results from this study were found using linalool isolated
from orange juice and evaluated on a different cell line, which could have led to the differing
results. The mechanisms by which linalool acts as an anti-inflammatory treatment on RAW
264.7 cells has yet to be determined and warrants further research.
The NO assay used for experimentation in the present study had some limitations. First, it
is hard to compare the effects of the treatments of a-terpineol, linalool, linalool oxide, and
eucalyptol directly with each other because they were applied as treatments on the RAW 264.7
cells at different concentrations. However, different concentrations were necessary to keep
consistent with the rest of the study and to be as representative as possible of the concentrations
of these compounds found in a fresh cranberry. Second, it is hard to determine if the results of
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this study would translate in vivo in humans, because a mouse cell line was used and the ability
of a-terpineol, linalool, linalool oxide, and eucalyptol to get into macrophages in humans has not
been determined and warrants future research. Third, the exact mechanisms by which aterpineol, linalool, linalool oxide, and eucalyptol provided their respective anti-inflammatory
effects in this study were not tested, and other experimental assays along with the NO assay
could have been conducted to determine levels of other inflammatory markers.
Chapter 7: Final Conclusions
Three objectives were addressed in the present study, number one was to extract, quantify
and identify the volatile and phenolic compounds in cranberries. Number two was to compare
the anti-inflammatory effect of the volatile and phenolic extracts from cranberries on RAW
264.7 mouse macrophage cells, and number three was to compare the anti-inflammatory effect of
four individual, more abundant volatile compounds from cranberries, α-terpineol, eucalyptol,
linalool oxide, and linalool, on RAW 264.7 mouse macrophage cells.
For objective number one, the Folin-Ciocalteu assay and HPLC were used. The total
phenolic content of the cranberries in this study was 1271 mg GAE equiv. per kg fresh weight.
Using HPLC, the concentration of total anthocyanins was found to be 936.6 ± 8.0 mg ACY-3-glu
equiv. per kg of fresh weight, the concentration of total flavonols was found to be 84.4 ± 1.0 mg
rutin equiv. per kg of fresh weight, and the concentration of total hydroxycinnamic acids was
found to be 14.7 ± 0.0 mg chlorogenic acid equiv. per kg of fresh weight. The total volatile
content of the cranberries used in this study was 3551.5 ppb. Using GC-MS, 25 individual
volatile compounds were identified, with the more prevalent individual compounds being aterpineol at 2321 ppb, linalool oxide at 224 ppb, eucalyptol at 189 ppb, and linalool at 41 ppb,
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which agreed with other cranberry studies finding a-terpineol to make up the majority of the
volatile fraction of cranberries.
For objective number two, the Griess Reagent System assay was used to measure NO
levels produced in vitro by RAW 264.7 cells when treated with volatile and phenolic extracts
before and after inducing inflammation using LPS. When the cells were treated with phenolic
and volatile extracts after inducing inflammation with LPS, the phenolic extract treatments and
the 1.8 ppm volatile extract treatment showed statistically significant, lower NO levels compared
to the positive control. When the cells were treated with phenolic and volatile extracts before
inducing inflammation with LPS, the 635.7 ppm and 317.8 ppm phenolic extract treatments and
1.8 ppm and 0.9 ppm volatile extract treatments showed statistically significant, lower NO levels
compared to the positive control. Treating the cells with the phenolic and volatile extracts before
inducing inflammation with LPS resulted in lower levels of NO in all treatments. Results
indicate that the total phenolic and volatile extracts from a cranberry act as an effective preventer
of inflammation and an effective treatment for pre-existing inflammation.
For the last objective, the Griess Reagent System assay was used to measure NO levels
produced in vitro by RAW 264.7 cells when treated with a-terpineol, linalool, linalool oxide,
and eucalyptol before and after inducing inflammation using LPS. When the cells were treated
with a-terpineol, linalool, linalool oxide, and eucalyptol after inducing inflammation with LPS,
only the 1160.3 ppb a-terpineol resulted in statistically significant, lower NO levels compared to
the positive control. However, when the cells were treated before LPS, a-terpineol 1160.3 ppb
and 580.2 ppb, linalool 20.7 ppb, linalool oxide112.2 ppb, and eucalyptol 94.5 ppb all showed
statistically significant lower NO levels than the positive control.

63

Future research is warranted to determine the mechanisms by which all treatments in this
study exhibited their respective anti-inflammatory effects. Uncovering the mechanisms by which
these treatments lower inflammation could aid in the treatment of diseases involving
inflammation such as obesity and periodontal disease. Future research is also necessary to
determine the bioavailability of cranberry volatile compounds, because as of now it is unknown
whether they can reach macrophage cells in humans at high enough doses to elicit the effects
seen in this in vitro study. Other recommendations for future research would be to re-run the
current study and measure additional inflammatory markers such as IL-6, TNF-a, and C-reactive
protein, and to investigate the possible synergistic effects of combinations of the volatile
standards, volatile extract, and phenolic extract.
In final summary, the most relevant finding of this study is that the volatile compounds
extracted from cranberries have a similar anti-inflammatory effect to the phenolic compounds at
a 353x lower concentration, whereas all previous studies have attributed the health benefits of
cranberries to phenolic compounds. These results provide exciting information for future
prevention and treatment of inflammation, as cranberries are low cost and easy to obtain in the
United States. Taking into consideration that all fruits and vegetables contain some level of these
volatile compounds, there are vast possibilities for future research on plant-based treatments for
inflammation.
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Appendix B: P-values for all statistical analysis
Table 1 p-values of phenolic and volatile treatments after LPS compared to positive control.
* indicates significance.
Level

- Level

Difference

Std Err Dif

p-Value

Control-0x+

Control-0x-

14.95807

2.141153

<.0001*

Control-0x+

Phenolic-2x

8.9912

2.141153

0.0014*

Control-0x+

Volatile-2x

7.36513

2.141153

0.0180*

Control-0x+

Phenolic-4x

6.6736

2.141153

0.0463*

Control-0x+

Volatile-4x

4.89847

2.141153

0.3096

Control-0x+

Phenolic-8x

3.39933

2.141153

0.7567

Control-0x+

Volatile-8x

3.2536

2.141153

0.7954

Table 2 p-values of phenolic and volatile treatments before LPS compared to positive control.
* indicates significance.
Level

- Level

Difference

Std Err Dif

p-Value

Control-0x+

Control-0x-

22.1686

0.9497967

<.0001*

Control-0x+

Phenolic-2x

12.03447

0.9497967

<.0001*

Control-0x+

Volatile-2x

10.792

0.9497967

<.0001*

Control-0x+

Phenolic-4x

5.91233

0.9497967

<.0001*

Control-0x+

Volatile-4x

2.99787

0.9497967

0.0415*

Control-0x+

Phenolic-8x

2.47493

0.9497967

0.1649

Control-0x+

Volatile-8x

0.3998

0.9497967

0.9999
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Table 3 p-values of standards treatments after LPS compared to positive control.
* indicates significance.
Level

- Level

Difference

Std Err Dif

p-Value

Control-0x+

Control-0x-

26.81753

1.960337

<.0001*

Control-0x+

AlphaTerpineol-2x

11.8572

1.960337

<.0001*

Control-0x+

Eucalyptol-2x

4.74773

1.960337

0.4684

Control-0x+

AlphaTerpineol-4x

3.947

1.960337

0.7575

Control-0x+

Linalool-2x

3.6574

1.960337

0.8422

Control-0x+

Linalool-oxide2x

3.3876

1.960337

0.9035

Control-0x+

Eucalyptol-4x

0.41193

1.960337

1

Control-0x+

Eucalyptol-8x

0.39287

1.960337

1

Control-0x+

Linalool-oxide4x

0.24367

1.960337

1

Control-0x+

Linalool-oxide8x

0.18

1.960337

1

Control-0x+

Linalool-4x

0.10967

1.960337

1

Control-0x+

Linalool-8x

0.06113

1.960337

1

Control-0x+

AlphaTerpineol-8x

0.00873

1.960337

1
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Table 4 p-values of standards treatments before LPS compared to positive control.
* indicates significance.
Level

- Level

Difference

Std Err Dif

p-Value

Control-0x+

Control-0x-

15.49727

0.8992653

<.0001*

Control-0x+

Alpha-Terpineol2x

6.59193

0.8992653

<.0001*

Control-0x+

Alpha-Terpineol4x

4.26693

0.8992653

0.0003*

Control-0x+

Eucalyptol-2x

3.888

0.8992653

0.0019*

Control-0x+

Linalool-oxide-2x

3.3372

0.8992653

0.0184*

Control-0x+

Linalool-2x

3.27107

0.8992653

0.0235*

Control-0x+

Alpha-Terpineol8x

0.49133

0.8992653

1

Control-0x+

Linalool-oxide-4x

0.43013

0.8992653

1

Control-0x+

Linalool-4x

0.22733

0.8992653

1

Control-0x+

Eucalyptol-8x

0.16533

0.8992653

1

Control-0x+

Linalool-oxide-8x

0.1298

0.8992653

1

Control-0x+

Eucalyptol-4x

0.07613

0.8992653

1

Control-0x+

Linalool-8x

0.03973

0.8992653

1
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